ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-5210891,Uptake and function of anthrax toxins,3/39,13/10899,1.1819660219459393e-5,0.0037704716100075463,0.0033592718518463535,MAP2K3/FURIN/MAP2K7,3
R-HSA-5339562,Uptake and actions of bacterial toxins,3/39,31/10899,1.776671639906643e-4,0.028337912656510953,0.025247439093410186,MAP2K3/FURIN/MAP2K7,3
R-HSA-1500931,Cell-Cell communication,4/39,129/10899,0.0011179243075537693,0.1188726180365508,0.1059086186103571,PVR/ACTN4/CD151/PARVB,4
R-HSA-9694614,Attachment and Entry,2/39,19/10899,0.002053092539336332,0.14700062303787872,0.1309690421390109,FURIN/SDC4,2
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",3/39,74/10899,0.0023040850005937104,0.14700062303787872,0.1309690421390109,FURIN/LDLR/PRKACA,3
R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,2/39,26/10899,0.0038409296037177,0.18871313406636067,0.1681324738423276,SDC4/XYLT2,2
R-HSA-446728,Cell junction organization,3/39,91/10899,0.004141040559449921,0.18871313406636067,0.1681324738423276,PVR/CD151/PARVB,3
R-HSA-9772572,Early SARS-CoV-2 Infection Events,2/39,38/10899,0.008086749872006107,0.24775109558299085,0.22073187859233634,FURIN/SDC4,2
R-HSA-9031628,NGF-stimulated transcription,2/39,39/10899,0.008504728484717106,0.24775109558299085,0.22073187859233634,FOSL1/NAB2,2
R-HSA-163841,"Gamma carboxylation, hypusine formation and arylsulfatase activation",2/39,42/10899,0.009815612215257934,0.24775109558299085,0.22073187859233634,FURIN/ARSJ,2
R-HSA-975634,Retinoid metabolism and transport,2/39,44/10899,0.010736295917713436,0.24775109558299085,0.22073187859233634,LDLR/SDC4,2
R-HSA-166520,Signaling by NTRKs,3/39,134/10899,0.012026503167650346,0.24775109558299085,0.22073187859233634,FOSL1/FURIN/NAB2,3
R-HSA-6806667,Metabolism of fat-soluble vitamins,2/39,48/10899,0.012687418699009348,0.24775109558299085,0.22073187859233634,LDLR/SDC4,2
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,2/39,50/10899,0.01371677468128804,0.24775109558299085,0.22073187859233634,SDC4/XYLT2,2
R-HSA-381038,XBP1(S) activates chaperone genes,2/39,50/10899,0.01371677468128804,0.24775109558299085,0.22073187859233634,CUL7/LMNA,2
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,2/39,51/10899,0.014244667114428443,0.24775109558299085,0.22073187859233634,EPHA2/EPHB4,2
R-HSA-381070,IRE1alpha activates chaperones,2/39,52/10899,0.014781280867799998,0.24775109558299085,0.22073187859233634,CUL7/LMNA,2
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,2/39,55/10899,0.01644279367861221,0.24775109558299085,0.22073187859233634,SDC4/XYLT2,2
R-HSA-6794361,Neurexins and neuroligins,2/39,55/10899,0.01644279367861221,0.24775109558299085,0.22073187859233634,SIPA1L1/HOMER2,2
R-HSA-3000171,Non-integrin membrane-ECM interactions,2/39,59/10899,0.018776288821452655,0.24775109558299085,0.22073187859233634,LAMA5/SDC4,2
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),2/39,61/10899,0.019992516967087176,0.24775109558299085,0.22073187859233634,FOSL1/NAB2,2
R-HSA-1474244,Extracellular matrix organization,4/39,300/10899,0.021715182806572197,0.24775109558299085,0.22073187859233634,FURIN/LAMA5/SDC4/CD151,4
R-HSA-450294,MAP kinase activation,2/39,64/10899,0.02187729101275967,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-448424,Interleukin-17 signaling,2/39,72/10899,0.027246126733455292,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-5683057,MAPK family signaling cascades,4/39,325/10899,0.028115166166232407,0.24775109558299085,0.22073187859233634,DUSP5/RCE1/PRKACA/ERBB2,4
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,2/39,79/10899,0.03233391380248136,0.24775109558299085,0.22073187859233634,FURIN/PRKACA,2
R-HSA-9664433,Leishmania parasite growth and survival,2/39,79/10899,0.03233391380248136,0.24775109558299085,0.22073187859233634,FURIN/PRKACA,2
R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,1/39,10/10899,0.03522668300126419,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-6794362,Protein-protein interactions at synapses,2/39,86/10899,0.037764849549313216,0.24775109558299085,0.22073187859233634,SIPA1L1/HOMER2,2
R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",1/39,11/10899,0.0386821113567557,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-446107,Type I hemidesmosome assembly,1/39,11/10899,0.0386821113567557,0.24775109558299085,0.22073187859233634,CD151,1
R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,1/39,11/10899,0.0386821113567557,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",1/39,12/10899,0.04212547998800942,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-2682334,EPH-Ephrin signaling,2/39,92/10899,0.04267847816259538,0.24775109558299085,0.22073187859233634,EPHA2/EPHB4,2
R-HSA-381119,Unfolded Protein Response (UPR),2/39,94/10899,0.044367210121231467,0.24775109558299085,0.22073187859233634,CUL7/LMNA,2
R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,1/39,13/10899,0.04555682988058474,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-1663150,The activation of arylsulfatases,1/39,13/10899,0.04555682988058474,0.24775109558299085,0.22073187859233634,ARSJ,1
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,1/39,13/10899,0.04555682988058474,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-9733458,Induction of Cell-Cell Fusion,1/39,13/10899,0.04555682988058474,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/39,97/10899,0.04694652321786859,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/39,97/10899,0.04694652321786859,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/39,97/10899,0.04694652321786859,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-3656237,Defective EXT2 causes exostoses 2,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-9005895,Pervasive developmental disorders,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-9675151,Disorders of Developmental Biology,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-9697154,Disorders of Nervous System Development,1/39,14/10899,0.048976201884503134,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/39,103/10899,0.05226637834316323,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/39,15/10899,0.05238363671468249,0.24775109558299085,0.22073187859233634,TEAD3,1
R-HSA-4419969,Depolymerisation of the Nuclear Lamina,1/39,15/10899,0.05238363671468249,0.24775109558299085,0.22073187859233634,LMNA,1
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/39,15/10899,0.05238363671468249,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,1/39,15/10899,0.05238363671468249,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/39,104/10899,0.05317332417828442,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/39,105/10899,0.05408593656409796,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/39,105/10899,0.05408593656409796,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-2187338,Visual phototransduction,2/39,105/10899,0.05408593656409796,0.24775109558299085,0.22073187859233634,LDLR/SDC4,2
R-HSA-175474,Assembly Of The HIV Virion,1/39,16/10899,0.05577917495137219,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-1963640,GRB2 events in ERBB2 signaling,1/39,16/10899,0.05577917495137219,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-1963642,PI3K events in ERBB2 signaling,1/39,16/10899,0.05577917495137219,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-392517,Rap1 signalling,1/39,16/10899,0.05577917495137219,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-9665348,Signaling by ERBB2 ECD mutants,1/39,16/10899,0.05577917495137219,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/39,108/10899,0.056857276445516844,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-166166,MyD88-independent TLR4 cascade ,2/39,110/10899,0.0587322633810312,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/39,110/10899,0.0587322633810312,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-164378,PKA activation in glucagon signalling,1/39,17/10899,0.05916285704058444,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-8934593,Regulation of RUNX1 Expression and Activity,1/39,17/10899,0.05916285704058444,0.24775109558299085,0.22073187859233634,PML,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2/39,113/10899,0.061584912333067954,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,2/39,113/10899,0.061584912333067954,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-1912420,Pre-NOTCH Processing in Golgi,1/39,18/10899,0.06253472329452836,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-446353,Cell-extracellular matrix interactions,1/39,18/10899,0.06253472329452836,0.24775109558299085,0.22073187859233634,PARVB,1
R-HSA-187037,Signaling by NTRK1 (TRKA),2/39,115/10899,0.06351289796791959,0.24775109558299085,0.22073187859233634,FOSL1/NAB2,2
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,2/39,116/10899,0.06448461440033601,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,2/39,116/10899,0.06448461440033601,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,1/39,19/10899,0.06589481389203877,0.24775109558299085,0.22073187859233634,LMNA,1
R-HSA-3928664,Ephrin signaling,1/39,19/10899,0.06589481389203877,0.24775109558299085,0.22073187859233634,EPHB4,1
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,1/39,19/10899,0.06589481389203877,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-8963898,Plasma lipoprotein assembly,1/39,19/10899,0.06589481389203877,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-8964038,LDL clearance,1/39,19/10899,0.06589481389203877,0.24775109558299085,0.22073187859233634,LDLR,1
R-HSA-163615,PKA activation,1/39,20/10899,0.06924316887900694,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",1/39,20/10899,0.06924316887900694,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,1/39,20/10899,0.06924316887900694,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-3781860,Diseases associated with N-glycosylation of proteins,1/39,20/10899,0.06924316887900694,0.24775109558299085,0.22073187859233634,ALG12,1
R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,1/39,20/10899,0.06924316887900694,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-1630316,Glycosaminoglycan metabolism,2/39,124/10899,0.07243756986214127,0.24775109558299085,0.22073187859233634,SDC4/XYLT2,2
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,1/39,21/10899,0.07257982816880537,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-5621575,CD209 (DC-SIGN) signaling,1/39,21/10899,0.07257982816880537,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-2559580,Oxidative Stress Induced Senescence,2/39,125/10899,0.07345340557316389,0.24775109558299085,0.22073187859233634,MAP2K3/MAP2K7,2
R-HSA-111931,PKA-mediated phosphorylation of CREB,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,PRKACA,1
R-HSA-1181150,Signaling by NODAL,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,FURIN,1
R-HSA-1250196,SHC1 events in ERBB2 signaling,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-2024096,HS-GAG degradation,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,SDC4,1
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,LMNA,1
R-HSA-8863678,Neurodegenerative Diseases,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,LMNA,1
R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,1/39,22/10899,0.07590483154271732,0.24775109558299085,0.22073187859233634,ERBB2,1
R-HSA-1483206,Glycerophospholipid biosynthesis,2/39,129/10899,0.07756306055111994,0.24775109558299085,0.22073187859233634,OSBPL10/PNPLA2,2
R-HSA-5673001,RAF/MAP kinase cascade,3/39,280/10899,0.07790255432542675,0.24775109558299085,0.22073187859233634,DUSP5/RCE1/ERBB2,3
R-HSA-112409,RAF-independent MAPK1/3 activation,1/39,23/10899,0.07921821865036072,0.24775109558299085,0.22073187859233634,DUSP5,1
R-HSA-1482801,Acyl chain remodelling of PS,1/39,23/10899,0.07921821865036072,0.24775109558299085,0.22073187859233634,OSBPL10,1
R-HSA-373753,Nephrin family interactions,1/39,23/10899,0.07921821865036072,0.24775109558299085,0.22073187859233634,ACTN4,1
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/39,23/10899,0.07921821865036072,0.24775109558299085,0.22073187859233634,MAP2K7,1
R-HSA-5684996,MAPK1/MAPK3 signaling,3/39,286/10899,0.0818489091355568,0.25005233165646235,0.22278214666637464,DUSP5/RCE1/ERBB2,3
R-HSA-163560,Triglyceride catabolism,1/39,24/10899,0.08252002901011046,0.25005233165646235,0.22278214666637464,PRKACA,1
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/39,24/10899,0.08252002901011046,0.25005233165646235,0.22278214666637464,MAP2K3,1
R-HSA-400685,Sema4D in semaphorin signaling,1/39,25/10899,0.08581030200952222,0.25005233165646235,0.22278214666637464,ERBB2,1
R-HSA-9664565,Signaling by ERBB2 KD Mutants,1/39,25/10899,0.08581030200952222,0.25005233165646235,0.22278214666637464,ERBB2,1
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,1/39,25/10899,0.08581030200952222,0.25005233165646235,0.22278214666637464,LMNA,1
R-HSA-449147,Signaling by Interleukins,4/39,473/10899,0.08735487882779873,0.25005233165646235,0.22278214666637464,MAP2K3/LAMA5/PRKACA/MAP2K7,4
R-HSA-71387,Metabolism of carbohydrates,3/39,295/10899,0.08793037739481147,0.25005233165646235,0.22278214666637464,SDC4/PRKACA/XYLT2,3
R-HSA-1227990,Signaling by ERBB2 in Cancer,1/39,26/10899,0.08908907690575452,0.25005233165646235,0.22278214666637464,ERBB2,1
R-HSA-180024,DARPP-32 events,1/39,26/10899,0.08908907690575452,0.25005233165646235,0.22278214666637464,PRKACA,1
R-HSA-1474228,Degradation of the extracellular matrix,2/39,140/10899,0.08922756470721598,0.25005233165646235,0.22278214666637464,FURIN/LAMA5,2
R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",1/39,27/10899,0.09235639282598584,0.25005233165646235,0.22278214666637464,NPAS2,1
R-HSA-191273,Cholesterol biosynthesis,1/39,27/10899,0.09235639282598584,0.25005233165646235,0.22278214666637464,DHCR7,1
R-HSA-3000170,Syndecan interactions,1/39,27/10899,0.09235639282598584,0.25005233165646235,0.22278214666637464,SDC4,1
R-HSA-9648002,RAS processing,1/39,27/10899,0.09235639282598584,0.25005233165646235,0.22278214666637464,RCE1,1
R-HSA-3781865,Diseases of glycosylation,2/39,143/10899,0.09249584681963184,0.25005233165646235,0.22278214666637464,SDC4/ALG12,2
R-HSA-3295583,TRP channels,1/39,28/10899,0.09561228876783501,0.2504917184831278,0.22317361488349943,TRPM4,1
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/39,28/10899,0.09561228876783501,0.2504917184831278,0.22317361488349943,NAB2,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/39,146/10899,0.09579934061110217,0.2504917184831278,0.22317361488349943,MAP2K3/MAP2K7,2
R-HSA-8856828,Clathrin-mediated endocytosis,2/39,146/10899,0.09579934061110217,0.2504917184831278,0.22317361488349943,TRIP10/LDLR,2
R-HSA-9006925,Intracellular signaling by second messengers,3/39,309/10899,0.09776411540894599,0.2535508358979981,0.22589911134287902,PML/PRKACA/ERBB2,3
R-HSA-8863795,Downregulation of ERBB2 signaling,1/39,29/10899,0.09885680359977833,0.25431709958330073,0.22658180791120666,ERBB2,1
R-HSA-3000157,Laminin interactions,1/39,30/10899,0.10208997606156367,0.2544273622159282,0.22668004553143248,LAMA5,1
R-HSA-3928663,EPHA-mediated growth cone collapse,1/39,30/10899,0.10208997606156367,0.2544273622159282,0.22668004553143248,EPHA2,1
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,1/39,30/10899,0.10208997606156367,0.2544273622159282,0.22668004553143248,PML,1
R-HSA-8874081,MET activates PTK2 signaling,1/39,30/10899,0.10208997606156367,0.2544273622159282,0.22668004553143248,LAMA5,1
R-HSA-2022928,HS-GAG biosynthesis,1/39,31/10899,0.10531184476462785,0.2604223137978006,0.2320212002158263,SDC4,1
R-HSA-2871796,FCERI mediated MAPK activation,1/39,32/10899,0.10852244819250556,0.2639945339236877,0.23520384147630974,MAP2K7,1
R-HSA-1592389,Activation of Matrix Metalloproteinases,1/39,33/10899,0.11172182470124714,0.2639945339236877,0.23520384147630974,FURIN,1
R-HSA-163359,Glucagon signaling in metabolic regulation,1/39,33/10899,0.11172182470124714,0.2639945339236877,0.23520384147630974,PRKACA,1
R-HSA-418990,Adherens junctions interactions,1/39,33/10899,0.11172182470124714,0.2639945339236877,0.23520384147630974,PVR,1
R-HSA-8963899,Plasma lipoprotein remodeling,1/39,33/10899,0.11172182470124714,0.2639945339236877,0.23520384147630974,FURIN,1
R-HSA-9022692,Regulation of MECP2 expression and activity,1/39,33/10899,0.11172182470124714,0.2639945339236877,0.23520384147630974,PRKACA,1
R-HSA-9658195,Leishmania infection,2/39,164/10899,0.11630053775572867,0.27279317311821655,0.24304291945856607,FURIN/PRKACA,2
R-HSA-168898,Toll-like Receptor Cascades,2/39,168/10899,0.12100091612655396,0.2766724839809482,0.24649916078157402,MAP2K3/MAP2K7,2
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,2/39,168/10899,0.12100091612655396,0.2766724839809482,0.24649916078157402,PRKACA/EHD2,2
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/39,36/10899,0.12125297436943916,0.2766724839809482,0.24649916078157402,FURIN,1
R-HSA-111933,Calmodulin induced events,1/39,37/10899,0.12440782422671526,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-111997,CaM pathway,1/39,37/10899,0.12440782422671526,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-8964043,Plasma lipoprotein clearance,1/39,37/10899,0.12440782422671526,0.2766724839809482,0.24649916078157402,LDLR,1
R-HSA-8979227,Triglyceride metabolism,1/39,37/10899,0.12440782422671526,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-111465,Apoptotic cleavage of cellular proteins,1/39,38/10899,0.12755163704711303,0.2766724839809482,0.24649916078157402,LMNA,1
R-HSA-3232142,SUMOylation of ubiquitinylation proteins,1/39,38/10899,0.12755163704711303,0.2766724839809482,0.24649916078157402,PML,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/39,38/10899,0.12755163704711303,0.2766724839809482,0.24649916078157402,ERBB2,1
R-HSA-9013424,RHOV GTPase cycle,1/39,38/10899,0.12755163704711303,0.2766724839809482,0.24649916078157402,EPHA2,1
R-HSA-111996,Ca-dependent events,1/39,39/10899,0.13068445043033394,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-73933,Resolution of Abasic Sites (AP sites),1/39,39/10899,0.13068445043033394,0.2766724839809482,0.24649916078157402,PNKP,1
R-HSA-8853659,RET signaling,1/39,40/10899,0.13380630185144027,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-9013420,RHOU GTPase cycle,1/39,40/10899,0.13380630185144027,0.2766724839809482,0.24649916078157402,EPHA2,1
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/39,40/10899,0.13380630185144027,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/39,41/10899,0.13691722866125655,0.2766724839809482,0.24649916078157402,SDC4,1
R-HSA-8875878,MET promotes cell motility,1/39,41/10899,0.13691722866125655,0.2766724839809482,0.24649916078157402,LAMA5,1
R-HSA-9717207,"Sensory perception of sweet, bitter, and umami (glutamate) taste",1/39,41/10899,0.13691722866125655,0.2766724839809482,0.24649916078157402,TRPM4,1
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/39,42/10899,0.14001726808676895,0.2766724839809482,0.24649916078157402,DHCR7,1
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1/39,42/10899,0.14001726808676895,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-3928662,EPHB-mediated forward signaling,1/39,42/10899,0.14001726808676895,0.2766724839809482,0.24649916078157402,EPHB4,1
R-HSA-9696264,RND3 GTPase cycle,1/39,42/10899,0.14001726808676895,0.2766724839809482,0.24649916078157402,EPHA2,1
R-HSA-9696273,RND1 GTPase cycle,1/39,42/10899,0.14001726808676895,0.2766724839809482,0.24649916078157402,EPHA2,1
R-HSA-1489509,DAG and IP3 signaling,1/39,43/10899,0.14310645723152493,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,1/39,43/10899,0.14310645723152493,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/39,43/10899,0.14310645723152493,0.2766724839809482,0.24649916078157402,DUSP5,1
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,1/39,43/10899,0.14310645723152493,0.2766724839809482,0.24649916078157402,PRKACA,1
R-HSA-9696270,RND2 GTPase cycle,1/39,43/10899,0.14310645723152493,0.2766724839809482,0.24649916078157402,EPHA2,1
R-HSA-1566948,Elastic fibre formation,1/39,44/10899,0.14618483307603147,0.28092145633285565,0.25028474908388393,FURIN,1
R-HSA-196854,Metabolism of vitamins and cofactors,2/39,190/10899,0.1476448583065288,0.2820282023939083,0.2512707957312498,LDLR/SDC4,2
R-HSA-9634597,GPER1 signaling,1/39,45/10899,0.14925243247815378,0.28340194024125626,0.2524947165983804,PRKACA,1
R-HSA-1660662,Glycosphingolipid metabolism,1/39,46/10899,0.15230929217350608,0.2858039070785202,0.2546347299495148,ARSJ,1
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/39,46/10899,0.15230929217350608,0.2858039070785202,0.2546347299495148,FURIN,1
R-HSA-9707616,Heme signaling,1/39,47/10899,0.1553554487758495,0.28813016371799993,0.2567072898988945,NPAS2,1
R-HSA-9717189,Sensory perception of taste,1/39,47/10899,0.1553554487758495,0.28813016371799993,0.2567072898988945,TRPM4,1
R-HSA-2559583,Cellular Senescence,2/39,197/10899,0.15636696891796484,0.2883298444209872,0.2568851938414999,MAP2K3/MAP2K7,2
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",1/39,48/10899,0.15839093877748445,0.29038338775872147,0.25871478203218873,PRKACA,1
R-HSA-1227986,Signaling by ERBB2,1/39,50/10899,0.16443006434287355,0.29973251728786665,0.2670443150230127,ERBB2,1
R-HSA-112043,PLC beta mediated events,1/39,51/10899,0.1674337722874425,0.3017591715236958,0.2688499465810852,PRKACA,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/39,51/10899,0.1674337722874425,0.3017591715236958,0.2688499465810852,FURIN,1
R-HSA-2980766,Nuclear Envelope Breakdown,1/39,52/10899,0.17042695839370992,0.3020344429310748,0.2690951974637525,LMNA,1
R-HSA-445717,Aquaporin-mediated transport,1/39,52/10899,0.17042695839370992,0.3020344429310748,0.2690951974637525,PRKACA,1
R-HSA-75153,Apoptotic execution phase,1/39,52/10899,0.17042695839370992,0.3020344429310748,0.2690951974637525,LMNA,1
R-HSA-1483257,Phospholipid metabolism,2/39,212/10899,0.17538082816953957,0.30720678949556407,0.27370345871573104,OSBPL10/PNPLA2,2
R-HSA-8848021,Signaling by PTK6,1/39,54/10899,0.17638190853559954,0.30720678949556407,0.27370345871573104,ERBB2,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/39,54/10899,0.17638190853559954,0.30720678949556407,0.27370345871573104,ERBB2,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/39,55/10899,0.17934374399591468,0.30720678949556407,0.27370345871573104,DHCR7,1
R-HSA-9700206,Signaling by ALK in cancer,1/39,55/10899,0.17934374399591468,0.30720678949556407,0.27370345871573104,RRBP1,1
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,1/39,55/10899,0.17934374399591468,0.30720678949556407,0.27370345871573104,RRBP1,1
R-HSA-112316,Neuronal System,3/39,410/10899,0.18008673866981342,0.30720678949556407,0.27370345871573104,SIPA1L1/PRKACA/HOMER2,3
R-HSA-112040,G-protein mediated events,1/39,56/10899,0.18229520046807934,0.30768343359427147,0.27412812100463063,PRKACA,1
R-HSA-5578775,Ion homeostasis,1/39,56/10899,0.18229520046807934,0.30768343359427147,0.27412812100463063,PRKACA,1
R-HSA-186797,Signaling by PDGF,1/39,58/10899,0.1881671179968991,0.31592268758426745,0.28146881916433664,FURIN,1
R-HSA-9013406,RHOQ GTPase cycle,1/39,59/10899,0.19108764953440693,0.31899661768941884,0.28420751287293544,TRIP10,1
R-HSA-5610780,Degradation of GLI1 by the proteasome,1/39,60/10899,0.19399794304622964,0.31899661768941884,0.28420751287293544,PRKACA,1
R-HSA-5610783,Degradation of GLI2 by the proteasome,1/39,60/10899,0.19399794304622964,0.31899661768941884,0.28420751287293544,PRKACA,1
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,1/39,60/10899,0.19399794304622964,0.31899661768941884,0.28420751287293544,PRKACA,1
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,1/39,61/10899,0.19689803348088197,0.3221049881046223,0.28697689090330974,CD151,1
R-HSA-8986944,Transcriptional Regulation by MECP2,1/39,62/10899,0.1997879556707921,0.3251650911172586,0.2897032654732216,PRKACA,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,3/39,433/10899,0.20103037813326347,0.32552634834777183,0.2900251247447563,LMNA/RRBP1/ERBB2,3
R-HSA-1442490,Collagen degradation,1/39,64/10899,0.20553743406791303,0.329479605365147,0.2935472478092384,FURIN,1
R-HSA-421270,Cell-cell junction organization,1/39,64/10899,0.20553743406791303,0.329479605365147,0.2935472478092384,PVR,1
R-HSA-373755,Semaphorin interactions,1/39,65/10899,0.2083970593629153,0.3323933096838499,0.2961431896209849,ERBB2,1
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,1/39,67/10899,0.21408625400527004,0.33976873148100073,0.30271426332245566,LMNA,1
R-HSA-380259,Loss of Nlp from mitotic centrosomes,1/39,70/10899,0.22254541825799545,0.3463023825575637,0.3085353680598653,PRKACA,1
R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,1/39,70/10899,0.22254541825799545,0.3463023825575637,0.3085353680598653,PRKACA,1
R-HSA-400253,Circadian Clock,1/39,70/10899,0.22254541825799545,0.3463023825575637,0.3085353680598653,NPAS2,1
R-HSA-9772573,Late SARS-CoV-2 Infection Events,1/39,70/10899,0.22254541825799545,0.3463023825575637,0.3085353680598653,FURIN,1
R-HSA-5668914,Diseases of metabolism,2/39,249/10899,0.22365665386757966,0.3463420999211549,0.30857075393074357,SDC4/ALG12,2
R-HSA-70171,Glycolysis,1/39,71/10899,0.2253453747348575,0.34727137459139873,0.3093986838464862,PRKACA,1
R-HSA-8854518,AURKA Activation by TPX2,1/39,73/10899,0.23091584259858122,0.3541449701391703,0.3155226594211383,PRKACA,1
R-HSA-9013408,RHOG GTPase cycle,1/39,74/10899,0.23368642103370574,0.35667927420934037,0.31778057758297934,EPHA2,1
R-HSA-2995410,Nuclear Envelope (NE) Reassembly,1/39,75/10899,0.23644727365076657,0.35917466806949777,0.32000382900103747,LMNA,1
R-HSA-3000178,ECM proteoglycans,1/39,76/10899,0.2391984336958165,0.3616317552083671,0.3221929513488175,LAMA5,1
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/39,77/10899,0.24193993430432303,0.36227242783087926,0.3227637535533325,PML,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/39,78/10899,0.2446718085015257,0.36227242783087926,0.3227637535533325,ERBB2,1
R-HSA-422356,Regulation of insulin secretion,1/39,78/10899,0.2446718085015257,0.36227242783087926,0.3227637535533325,PRKACA,1
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",1/39,78/10899,0.2446718085015257,0.36227242783087926,0.3227637535533325,ALG12,1
R-HSA-1221632,Meiotic synapsis,1/39,79/10899,0.2473940892027955,0.36227242783087926,0.3227637535533325,LMNA,1
R-HSA-6806834,Signaling by MET,1/39,79/10899,0.2473940892027955,0.36227242783087926,0.3227637535533325,LAMA5,1
R-HSA-1257604,PIP3 activates AKT signaling,2/39,267/10899,0.24757175318850055,0.36227242783087926,0.3227637535533325,PML/ERBB2,2
R-HSA-438064,Post NMDA receptor activation events,1/39,80/10899,0.250106809213987,0.36431083168612716,0.32457985334187206,PRKACA,1
R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,1/39,82/10899,0.255503697844103,0.3688039801460129,0.3285829884158505,PRKACA,1
R-HSA-380287,Centrosome maturation,1/39,82/10899,0.255503697844103,0.3688039801460129,0.3285829884158505,PRKACA,1
R-HSA-6802957,Oncogenic MAPK signaling,1/39,84/10899,0.2608627346618464,0.3748432989059865,0.3339636716865743,LMNA,1
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,1/39,88/10899,0.2714682853028666,0.386599924158993,0.34443814394630634,PRKACA,1
R-HSA-9013404,RAC2 GTPase cycle,1/39,88/10899,0.2714682853028666,0.386599924158993,0.34443814394630634,EPHA2,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/39,89/10899,0.27409641747132363,0.3871587027582386,0.34493598331867487,PRKACA,1
R-HSA-1474290,Collagen formation,1/39,90/10899,0.27671531106231473,0.3871587027582386,0.34493598331867487,CD151,1
R-HSA-428157,Sphingolipid metabolism,1/39,90/10899,0.27671531106231473,0.3871587027582386,0.34493598331867487,ARSJ,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/39,90/10899,0.27671531106231473,0.3871587027582386,0.34493598331867487,PML,1
R-HSA-70326,Glucose metabolism,1/39,91/10899,0.2793249977001695,0.3876475747428335,0.3453715399457682,PRKACA,1
R-HSA-111885,Opioid Signalling,1/39,92/10899,0.2819255089038789,0.3876475747428335,0.3453715399457682,PRKACA,1
R-HSA-73884,Base Excision Repair,1/39,92/10899,0.2819255089038789,0.3876475747428335,0.3453715399457682,PNKP,1
R-HSA-877300,Interferon gamma signaling,1/39,92/10899,0.2819255089038789,0.3876475747428335,0.3453715399457682,PML,1
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/39,93/10899,0.2845168760874405,0.3878670233841603,0.34556705597664833,FURIN,1
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,1/39,93/10899,0.2845168760874405,0.3878670233841603,0.34556705597664833,PRKACA,1
R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,1/39,94/10899,0.2870991305601954,0.38807043495212856,0.3457482839038928,PRKACA,1
R-HSA-9013423,RAC3 GTPase cycle,1/39,94/10899,0.2870991305601954,0.38807043495212856,0.3457482839038928,EPHA2,1
R-HSA-9694516,SARS-CoV-2 Infection,2/39,298/10899,0.28897110969531103,0.38895267507512327,0.3465343087618653,FURIN/SDC4,2
R-HSA-8878159,Transcriptional regulation by RUNX3,1/39,96/10899,0.29223642608940925,0.391695041691267,0.34897759860300975,TEAD3,1
R-HSA-5620912,Anchoring of the basal body to the plasma membrane,1/39,98/10899,0.29733764388600525,0.3968648887014045,0.3535836328968131,PRKACA,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/39,99/10899,0.29987480080559115,0.3969297155891435,0.3536413898995833,PRKACA,1
R-HSA-9679191,Potential therapeutics for SARS,1/39,99/10899,0.29987480080559115,0.3969297155891435,0.3536413898995833,FURIN,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/39,104/10899,0.31242729009557857,0.41110542239575426,0.3662711237315745,ERBB2,1
R-HSA-9645723,Diseases of programmed cell death,1/39,105/10899,0.3149113415718432,0.41110542239575426,0.3662711237315745,LMNA,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/39,106/10899,0.3173866480086317,0.41110542239575426,0.3662711237315745,ERBB2,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/39,106/10899,0.3173866480086317,0.41110542239575426,0.3662711237315745,LDLR,1
R-HSA-163685,Integration of energy metabolism,1/39,108/10899,0.32231114558093166,0.41110542239575426,0.3662711237315745,PRKACA,1
R-HSA-194138,Signaling by VEGF,1/39,108/10899,0.32231114558093166,0.41110542239575426,0.3662711237315745,PRKACA,1
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,1/39,108/10899,0.32231114558093166,0.41110542239575426,0.3662711237315745,SLC12A4,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/39,108/10899,0.32231114558093166,0.41110542239575426,0.3662711237315745,LAMA5,1
R-HSA-8957275,Post-translational protein phosphorylation,1/39,108/10899,0.32231114558093166,0.41110542239575426,0.3662711237315745,PNPLA2,1
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/39,109/10899,0.3247603963753294,0.41110542239575426,0.3662711237315745,FURIN,1
R-HSA-2672351,Stimuli-sensing channels,1/39,109/10899,0.3247603963753294,0.41110542239575426,0.3662711237315745,TRPM4,1
R-HSA-977225,Amyloid fiber formation,1/39,111/10899,0.3296330503821686,0.4156242809166474,0.37029716498100906,FURIN,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/39,113/10899,0.3344714376612219,0.41841721025070505,0.3727855032756653,ERBB2,1
R-HSA-5610787,Hedgehog 'off' state,1/39,113/10899,0.3344714376612219,0.41841721025070505,0.3727855032756653,PRKACA,1
R-HSA-1989781,PPARA activates gene expression,1/39,117/10899,0.3440463491965351,0.4287140054441199,0.3819593514928638,NPAS2,1
R-HSA-1500620,Meiosis,1/39,118/10899,0.3464190251732865,0.42999093007890427,0.38309701739417307,LMNA,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/39,119/10899,0.34878333813296025,0.43124761575354387,0.3842166515540566,NPAS2,1
R-HSA-9006936,Signaling by TGFB family members,1/39,122/10899,0.35582638547281964,0.43825720836227594,0.39046179263426656,FURIN,1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/39,125/10899,0.36279519327611875,0.445121794827238,0.3965777416378626,PNPLA2,1
R-HSA-114608,Platelet degranulation ,1/39,129/10899,0.37197276951307623,0.45463338496042655,0.40505201761859483,ACTN4,1
R-HSA-6809371,Formation of the cornified envelope,1/39,130/10899,0.37424696282681724,0.45566710359448365,0.40597300105761613,FURIN,1
R-HSA-5576891,Cardiac conduction,1/39,132/10899,0.3787713025519268,0.45942222628921925,0.4093185979148299,PRKACA,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1/39,134/10899,0.38326376310758803,0.4596283474861676,0.40950223996457763,PVR,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/39,134/10899,0.38326376310758803,0.4596283474861676,0.40950223996457763,MAP2K7,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/39,134/10899,0.38326376310758803,0.4596283474861676,0.40950223996457763,ACTN4,1
R-HSA-9609690,HCMV Early Events,1/39,135/10899,0.3854981071149084,0.46057639014852353,0.4103468910744146,PML,1
R-HSA-162599,Late Phase of HIV Life Cycle,1/39,136/10899,0.38772456324854987,0.46150796894137097,0.41117687382996254,FURIN,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/39,137/10899,0.3899431586246821,0.4624232996329873,0.41199238046826125,SDC4,1
R-HSA-6807070,PTEN Regulation,1/39,140/10899,0.3965520500108808,0.468518903531374,0.41742321053776926,PML,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/39,142/10899,0.4009191668756541,0.4701956405637267,0.4189170861316819,PRKACA,1
R-HSA-68875,Mitotic Prophase,1/39,142/10899,0.4009191668756541,0.4701956405637267,0.4189170861316819,LMNA,1
R-HSA-1474165,Reproduction,1/39,143/10899,0.4030911620873161,0.4710112846368273,0.4196437777658583,LMNA,1
R-HSA-162587,HIV Life Cycle,1/39,149/10899,0.415962911405074,0.48251697722988585,0.4298946835573971,FURIN,1
R-HSA-5358351,Signaling by Hedgehog,1/39,149/10899,0.415962911405074,0.48251697722988585,0.4298946835573971,PRKACA,1
R-HSA-8957322,Metabolism of steroids,1/39,154/10899,0.42648242475328,0.4929271503488997,0.4391695449404485,DHCR7,1
R-HSA-418555,G alpha (s) signalling events,1/39,157/10899,0.4327052725991425,0.49831401429287525,0.4439689287545828,PRKACA,1
R-HSA-9679506,SARS-CoV Infections,2/39,413/10899,0.4381087928601979,0.49998956433723946,0.44546174681093775,FURIN/SDC4,2
R-HSA-5633007,Regulation of TP53 Activity,1/39,160/10899,0.4388623135248497,0.49998956433723946,0.44546174681093775,PML,1
R-HSA-9609646,HCMV Infection,1/39,160/10899,0.4388623135248497,0.49998956433723946,0.44546174681093775,PML,1
R-HSA-68886,M Phase,2/39,418/10899,0.4442703371600304,0.5043495998364758,0.4493462859457134,LMNA/PRKACA,2
R-HSA-109581,Apoptosis,1/39,180/10899,0.47827685553054144,0.5410294926036976,0.48202594622339,LMNA,1
R-HSA-9012999,RHO GTPase cycle,2/39,449/10899,0.48166316622070493,0.5414762156275039,0.4824239505673191,EPHA2/TRIP10,2
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/39,182/10899,0.4820665994928248,0.5414762156275039,0.4824239505673191,PML,1
R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,1/39,184/10899,0.4858295159948549,0.5437881249205568,0.48448372786190513,RRP1,1
R-HSA-9013149,RAC1 GTPase cycle,1/39,185/10899,0.48770097179291383,0.5439741608459424,0.48464947509785333,EPHA2,1
R-HSA-983712,Ion channel transport,1/39,186/10899,0.4895657899840725,0.5441515226652235,0.4848074942075906,TRPM4,1
R-HSA-2990846,SUMOylation,1/39,188/10899,0.49327560516712765,0.5463712432233115,0.4867851366780865,PML,1
R-HSA-8868773,rRNA processing in the nucleus and cytosol,1/39,194/10899,0.5042481165035693,0.5565922116423481,0.4958914276305361,RRP1,1
R-HSA-69275,G2/M Transition,1/39,196/10899,0.5078539089948757,0.5586392998943633,0.4977152647136712,PRKACA,1
R-HSA-453274,Mitotic G2-G2/M phases,1/39,198/10899,0.5114341428829162,0.5606443009609976,0.49950160455195286,PRKACA,1
R-HSA-913531,Interferon Signaling,1/39,200/10899,0.5149889945977939,0.5625637221023765,0.5012116976328712,PML,1
R-HSA-5617833,Cilium Assembly,1/39,201/10899,0.5167569569504142,0.5625637221023765,0.5012116976328712,PRKACA,1
R-HSA-68877,Mitotic Prometaphase,1/39,204/10899,0.5220232513102308,0.5625637221023765,0.5012116976328712,PRKACA,1
R-HSA-72312,rRNA processing,1/39,204/10899,0.5220232513102308,0.5625637221023765,0.5012116976328712,RRP1,1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/39,205/10899,0.5237662240263504,0.5625637221023765,0.5012116976328712,PRKACA,1
R-HSA-397014,Muscle contraction,1/39,205/10899,0.5237662240263504,0.5625637221023765,0.5012116976328712,PRKACA,1
R-HSA-5357801,Programmed Cell Death,1/39,210/10899,0.5323886130967843,0.5699059314693765,0.5077531809824506,LMNA,1
R-HSA-6805567,Keratinization,1/39,214/10899,0.5391768289315415,0.5752421686594038,0.5125074592906749,FURIN,1
R-HSA-376176,Signaling by ROBO receptors,1/39,218/10899,0.5458689926208101,0.5804406954867947,0.5171390456407675,PRKACA,1
R-HSA-5689880,Ub-specific processing proteases,1/39,220/10899,0.5491794693102638,0.5820207664783195,0.5185467973903523,RCE1,1
R-HSA-162906,HIV Infection,1/39,231/10899,0.5669710440992914,0.5988866326744171,0.5335733074479215,FURIN,1
R-HSA-157118,Signaling by NOTCH,1/39,236/10899,0.5748301656851775,0.6028422542778832,0.5370975372216745,FURIN,1
R-HSA-68882,Mitotic Anaphase,1/39,236/10899,0.5748301656851775,0.6028422542778832,0.5370975372216745,LMNA,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/39,237/10899,0.576385227444371,0.6028422542778832,0.5370975372216745,LMNA,1
R-HSA-8878171,Transcriptional regulation by RUNX1,1/39,239/10899,0.5794787432010786,0.6037280070282625,0.537886691627226,PML,1
R-HSA-8951664,Neddylation,1/39,240/10899,0.5810172356040018,0.6037280070282625,0.537886691627226,CUL7,1
R-HSA-425407,SLC-mediated transmembrane transport,1/39,250/10899,0.5961036150833176,0.6173930299077218,0.5500614356544625,SLC12A4,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/39,263/10899,0.6149266144468741,0.6348271521312391,0.5655942289240539,ACTN4,1
R-HSA-112315,Transmission across Chemical Synapses,1/39,270/10899,0.6247051663182288,0.6428417679210161,0.5727347874564407,PRKACA,1
R-HSA-1852241,Organelle biogenesis and maintenance,1/39,296/10899,0.6589516263065376,0.6759021504559019,0.6021896737274163,PRKACA,1
R-HSA-5688426,Deubiquitination,1/39,298/10899,0.6614560212626358,0.6762963807140411,0.6025409100570569,RCE1,1
R-HSA-446203,Asparagine N-linked glycosylation,1/39,304/10899,0.6688621719130812,0.6816838109912872,0.6073407984413381,ALG12,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/39,309/10899,0.6749131640185093,0.6856601889232627,0.6108835209017683,CUL7,1
R-HSA-418594,G alpha (i) signalling events,1/39,318/10899,0.6855345840152687,0.6942397850821292,0.6185274442243026,PRKACA,1
R-HSA-73894,DNA Repair,1/39,336/10899,0.7057726861650246,0.7124730597678572,0.634772236057817,PNKP,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/39,362/10899,0.7327818586051918,0.7374050879970226,0.6569852293654385,PML,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/39,381/10899,0.750975598868272,0.7533371573552793,0.6711797805178201,CUL7,1
R-HSA-6798695,Neutrophil degranulation,1/39,482/10899,0.8291893552222361,0.8291893552222361,0.7387596961227644,TOM1,1
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,6/27,200/4383,0.0011082583340785005,0.034356008356433515,0.034356008356433515,MAP2K3/FOSL1/TRIP10/LDLR/DUSP5/SDC4,6
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,3/27,144/4383,0.057139341109136384,0.5727580332643413,0.5727580332643413,SIPA1L1/LDLR/ERBB2,3
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,2/27,74/4383,0.07526640345802327,0.5727580332643413,0.5727580332643413,DHCR7/LDLR,2
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,3/27,200/4383,0.12290677040574907,0.5727580332643413,0.5727580332643413,DHCR7/NAB2/HOMER2,3
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,3/27,200/4383,0.12290677040574907,0.5727580332643413,0.5727580332643413,MAP2K3/DHCR7/LDLR,3
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/27,36/4383,0.20016320409902444,0.5727580332643413,0.5727580332643413,LRPAP1,1
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,1/27,36/4383,0.20016320409902444,0.5727580332643413,0.5727580332643413,PML,1
HALLMARK_APICAL_SURFACE,HALLMARK_APICAL_SURFACE,1/27,44/4383,0.23908397802732795,0.5727580332643413,0.5727580332643413,EPHB4,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/27,158/4383,0.25412396429105055,0.5727580332643413,0.5727580332643413,FURIN/PRKACA,2
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,2/27,161/4383,0.26106596289549355,0.5727580332643413,0.5727580332643413,LMNA/ERBB2,2
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,1/27,49/4383,0.26247632267982546,0.5727580332643413,0.5727580332643413,SBNO2,1
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,1/27,54/4383,0.2851753749971293,0.5727580332643413,0.5727580332643413,FURIN,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,DHCR7/CD151,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,DUSP5/RCE1,2
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,PVR/SDC4,2
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,MAP2K3/BCAM,2
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,PVR/LDLR,2
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,EPHA2/PHLDA3,2
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,2/27,200/4383,0.3510452461942737,0.5727580332643413,0.5727580332643413,EPHA2/SLC12A4,2
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/27,100/4383,0.464754598402082,0.7106703183432389,0.7106703183432389,HOMER2,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/27,105/4383,0.4814218285550973,0.7106703183432389,0.7106703183432389,MAP2K3,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/27,138/4383,0.5795321821097402,0.7177247136580093,0.7177247136580093,FURIN,1
HALLMARK_DNA_REPAIR,HALLMARK_DNA_REPAIR,1/27,150/4383,0.6105640588920229,0.7177247136580093,0.7177247136580093,BCAM,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,1/27,199/4383,0.7158913163206908,0.7177247136580093,0.7177247136580093,FURIN,1
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,1/27,199/4383,0.7158913163206908,0.7177247136580093,0.7177247136580093,ACTN4,1
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,ACTN4,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,DHCR7,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,PML,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,XYLT2,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,SDC4,1
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,1/27,200/4383,0.7177247136580093,0.7177247136580093,0.7177247136580093,PML,1
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,5/50,68/21728,4.910733867334843e-7,5.027204298740206e-4,3.750647455226525e-4,EPHA2/MAP2K3/FOSL1/EPHB4/NAB2,5
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,8/50,341/21728,1.0251958255101264e-6,5.027204298740206e-4,3.750647455226525e-4,PVR/DHCR7/TRIP10/LDLR/DUSP5/SDC4/CRIM1/HOMER2,8
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,7/50,250/21728,1.6081214894609801e-6,5.027204298740206e-4,3.750647455226525e-4,PVR/DHCR7/TRIP10/LDLR/DUSP5/SDC4/HOMER2,7
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,6/50,161/21728,1.829545318084622e-6,5.027204298740206e-4,3.750647455226525e-4,SIPA1L1/CD151/EPHB4/SLC12A4/SSH3/TEAD3,6
REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,3/50,11/21728,1.8674607350446533e-6,5.027204298740206e-4,3.750647455226525e-4,MAP2K3/FURIN/MAP2K7,3
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,6/50,173/21728,2.7763500290487956e-6,6.228278565166131e-4,4.646733206513248e-4,EPHA2/MAP2K3/FOSL1/LDLR/DUSP5/NAB2,6
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,7/50,311/21728,6.780374703898124e-6,0.0013037691930638392,9.727033785742572e-4,EPHA2/LMNA/PHLDA3/SLC12A4/PML/TEAD3/LRPAP1,7
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,4/50,57/21728,8.957014557413642e-6,0.0013656124774002654,0.001018842811793113,EPHA2/FOSL1/DUSP5/NAB2,4
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,3/50,18/21728,9.131138407579785e-6,0.0013656124774002654,0.001018842811793113,EPHA2/FOSL1/DUSP5,3
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,3/50,19/21728,1.0825652114685348e-5,0.0014571327746366479,0.0010871233807799815,LDLR/SDC4/RRBP1,3
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,7/50,341/21728,1.2335462498120315e-5,0.0014997242584597684,0.0011188996188086487,EPHA2/MAP2K3/TRIP10/LDLR/SBNO2/SDC4/ARSJ,7
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,4/50,63/21728,1.337049858953731e-5,0.0014997242584597684,0.0011188996188086487,EPHA2/LDLR/DUSP5/SDC4,4
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,6/50,250/21728,2.2725287864233247e-5,0.002352941343481381,0.0017554594836014996,PVR/EPHA2/FOSL1/LDLR/DUSP5/SDC4,6
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,6/50,276/21728,3.9553242715174076e-5,0.003404079628343992,0.0025396824630016177,MAP2K3/DHCR7/LAMA5/EPHB4/RRBP1/ERBB2,6
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,3/50,29/21728,4.016584211760509e-5,0.003404079628343992,0.0025396824630016177,MAP2K3/FURIN/MAP2K7,3
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,5/50,167/21728,4.0464542387447155e-5,0.003404079628343992,0.0025396824630016177,FURIN/EPHB4/RRBP1/PARVB/LRPAP1,5
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,4/50,86/21728,4.584730717837923e-5,0.0036040034744852624,0.0026888396923898813,TRIP10/LDLR/CD151/PHLDA3,4
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,7/50,422/21728,4.8196183165479e-5,0.0036040034744852624,0.0026888396923898813,PVR/DHCR7/TRIP10/LDLR/DUSP5/SDC4/CRIM1,7
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,7/50,445/21728,6.730949422296075e-5,0.004768346274952903,0.0035575211905099478,EPHA2/ACTN4/DHCR7/DUSP5/SDC4/CD151/NAB2,7
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,3/50,39/21728,9.88439754467479e-5,0.006652199547566133,0.004963008030326184,PVR/FOSL1/ACTN4,3
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,3/50,41/21728,1.149216867079887e-4,0.007284467139533542,0.00543472405655353,EPHA2/FOSL1/PHLDA3,3
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,6/50,337/21728,1.1906261297900292e-4,0.007284467139533542,0.00543472405655353,CUL7/FURIN/SBNO2/LMNA/TEAD3/TRABD,6
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,5/50,216/21728,1.36481083508149e-4,0.007987110365302981,0.0059589452479072835,EPHA2/MAP2K3/FOSL1/DUSP5/SDC4,5
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,3/50,45/21728,1.5198975895737698e-4,0.008183128622265176,0.006105188633487901,FOSL1/LMNA/PHLDA3,3
WP_NEPHROTIC_SYNDROME,WP_NEPHROTIC_SYNDROME,3/50,45/21728,1.5198975895737698e-4,0.008183128622265176,0.006105188633487901,ACTN4/LMNA/CD151,3
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,3/50,46/21728,1.6233068398389095e-4,0.008403734640089124,0.006269776215410202,EPHA2/FOSL1/DUSP5,3
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,3/50,48/21728,1.843607696915527e-4,0.00886248557160107,0.006612036627283508,FOSL1/LDLR/DUSP5,3
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,3/50,48/21728,1.843607696915527e-4,0.00886248557160107,0.006612036627283508,MAP2K3/PRKACA/MAP2K7,3
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,4/50,125/21728,1.9589305316042782e-4,0.009092139639790891,0.006783374690201386,MAP2K3/DUSP5/SDC4/RRBP1,4
REACTOME_CELL_CELL_COMMUNICATION,REACTOME_CELL_CELL_COMMUNICATION,4/50,130/21728,2.2766868347515854e-4,0.010152284141444742,0.007574316939812533,PVR/ACTN4/CD151/PARVB,4
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,5/50,243/21728,2.3599187188135288e-4,0.010152284141444742,0.007574316939812533,LMNA/SLC12A4/BCAM/HOMER2/SH2D4A,5
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,4/50,132/21728,2.4136188152023162e-4,0.010152284141444742,0.007574316939812533,SDC4/CD151/SSH3/XYLT2,4
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,4/50,134/21728,2.5563835788226195e-4,0.010426946354834078,0.007779234239862135,EPHA2/LAMA5/EPHB4/ERBB2,4
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,6/50,395/21728,2.809696801896261e-4,0.010832494547637683,0.008081801672359702,EPHA2/ACTN4/LAMA5/CD151/SLC12A4/CRIM1,6
WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,2/50,11/21728,2.8167704990142564e-4,0.010832494547637683,0.008081801672359702,RCE1/LMNA,2
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,6/50,409/21728,3.383906320402534e-4,0.012634011371590917,0.009425859739186467,MAP2K3/FOSL1/TRIP10/DUSP5/SDC4/PML,6
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,6/50,411/21728,3.4729451764402964e-4,0.012634011371590917,0.009425859739186467,SDC4/EPHB4/CRIM1/PML/BCAM/HOMER2,6
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,6/50,414/21728,3.6099435269415465e-4,0.012782195461988338,0.009536415477232248,TRIP10/DUSP5/SDC4/LMNA/SLC12A4/PML,6
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,6/50,416/21728,3.7036078976043475e-4,0.012782195461988338,0.009536415477232248,DHCR7/OSBPL10/ERBB2/SSH3/HOMER2/SLC49A3,6
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,2/50,13/21728,3.982950661299276e-4,0.013402628975272063,0.00999930244968292,FOSL1/ERBB2,2
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,5/50,274/21728,4.097138097281946e-4,0.013450604582784145,0.010035095622097503,PVR/EPHA2/DUSP5/SH2D4A/MAP2K7,5
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,6/50,428/21728,4.3063839332639094e-4,0.013800935176602911,0.010296466847954312,PVR/LDLR/SBNO2/EPHB4/SLC12A4/RRBP1,6
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,3/50,67/21728,4.951731017834714e-4,0.015235316011544,0.01136661568390786,LDLR/DUSP5/SLC12A4,3
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,5/50,286/21728,4.980341043892541e-4,0.015235316011544,0.01136661568390786,LAMA5/DUSP5/RRBP1/PARVB/HOMER2,5
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,4/50,161/21728,5.129130052287899e-4,0.015341797889732249,0.011446058643000363,SIPA1L1/LDLR/DUSP5/TRPM4,4
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,6/50,446/21728,5.351713245953999e-4,0.015659578324030615,0.011683145163936192,EPHA2/MAP2K3/FOSL1/LAMA5/TEAD3/MAP2K7,6
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,4/50,164/21728,0.00054981854728569765,0.0157458673329053,0.011747522824424537,RRP1/PVR/MAP2K3/RRBP1,4
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,3/50,70/21728,5.630868341709522e-4,0.015789893308210453,0.011780369293839662,EPHA2/LMNA/EPHB4,3
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,3/50,71/21728,5.869796454186701e-4,0.015816685064727457,0.011800357825721433,FURIN/LDLR/PRKACA,3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,6/50,454/21728,5.875440217209308e-4,0.015816685064727457,0.011800357825721433,MAP2K3/FOSL1/TRIP10/LDLR/DUSP5/SDC4,6
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,3/50,74/21728,6.625210100171192e-4,0.017485358421236125,0.013045305336559995,ACTN4/LAMA5/CD151,3
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,2/50,17/21728,6.903884084309411e-4,0.017870438418231667,0.013332602057552993,ALG12/TRABD,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,6/50,474/21728,7.360237086940763e-4,0.018313760235604853,0.013663351266729516,MAP2K3/DHCR7/LDLR/DUSP5/PNKP/PARVB,6
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,4/50,179/21728,7.631797792925765e-4,0.018313760235604853,0.013663351266729516,TRIP10/EPHB4/RRBP1/ERBB2,4
AMIT_DELAYED_EARLY_GENES,AMIT_DELAYED_EARLY_GENES,2/50,18/21728,7.755455671838608e-4,0.018313760235604853,0.013663351266729516,FOSL1/NAB2,2
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,2/50,18/21728,7.755455671838608e-4,0.018313760235604853,0.013663351266729516,EPHA2/LMNA,2
PID_ANTHRAX_PATHWAY,PID_ANTHRAX_PATHWAY,2/50,18/21728,7.755455671838608e-4,0.018313760235604853,0.013663351266729516,MAP2K3/MAP2K7,2
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,3/50,83/21728,9.255022434931523e-4,0.02147803482313419,0.01602412232835694,MAP2K3/ERBB2/MAP2K7,3
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,3/50,88/21728,0.0010964682507736822,0.02501434348375214,0.018662456935559197,MAP2K3/LMNA/EPHB4,3
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,4/50,199/21728,0.0011310443881792321,0.025373095774820775,0.018930111338999783,ACTN4/LAMA5/ERBB2/PARVB,4
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,4/50,202/21728,0.001195298210069029,0.026374940832014967,0.019677558108815423,ACTN4/LAMA5/ERBB2/PARVB,4
REACTOME_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_JUNCTION_ORGANIZATION,3/50,92/21728,0.0012467073541295296,0.02706561449448947,0.02019284916535775,PVR/CD151/PARVB,3
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,2/50,23/21728,0.0012730468761819123,0.027198747545092918,0.020292175770719206,DHCR7/TOM1,2
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,5/50,357/21728,0.0013451758019206513,0.028290728584143696,0.021106870313031274,ACTN4/SIPA1L1/LDLR/LAMA5/SLC12A4,5
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,2/50,24/21728,0.0013867393668673526,0.02871617212005318,0.02142428106868752,DHCR7/ERBB2,2
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,3/50,99/21728,0.001539652871990491,0.03135400597932407,0.02339229037637848,EPHA2/PRKACA/TEAD3,3
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,4/50,219/21728,0.0016085556876747416,0.03135400597932407,0.02339229037637848,TRIP10/SLC12A4/TEAD3/TOM1,4
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,2/50,26/21728,0.0016281454166476557,0.03135400597932407,0.02339229037637848,SDC4/XYLT2,2
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,2/50,26/21728,0.0016281454166476557,0.03135400597932407,0.02339229037637848,DHCR7/LDLR,2
KEGG_GNRH_SIGNALING_PATHWAY,KEGG_GNRH_SIGNALING_PATHWAY,3/50,101/21728,0.001630594664600806,0.03135400597932407,0.02339229037637848,MAP2K3/PRKACA/MAP2K7,3
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,5/50,378/21728,0.0017294347183346112,0.032786184941949105,0.0244607964609521,MAP2K3/FURIN/LMNA/EPHB4/PML,5
PID_REELIN_PATHWAY,PID_REELIN_PATHWAY,2/50,28/21728,0.0018881047565403185,0.034813547976757106,0.025973351661708208,MAP2K7/LRPAP1,2
PID_TCR_CALCIUM_PATHWAY,PID_TCR_CALCIUM_PATHWAY,2/50,28/21728,0.0018881047565403185,0.034813547976757106,0.025973351661708208,FOSL1/PRKACA,2
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,3/50,107/21728,0.0019233955523837618,0.03498500558795329,0.02610127108071279,DUSP5/CRIM1/EPS8L1,3
WP_THERMOGENESIS,WP_THERMOGENESIS,3/50,108/21728,0.001975164589518685,0.03544762049989533,0.026446414293344923,MAP2K3/PRKACA/PNPLA2,3
WP_LIPID_METABOLISM_PATHWAY,WP_LIPID_METABOLISM_PATHWAY,2/50,29/21728,0.0020249891205716274,0.03586362310907119,0.026756781454644496,PRKACA/PNPLA2,2
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,3/50,114/21728,0.0023040596727538537,0.03990479751178245,0.02977178136094507,FOSL1/LDLR/ERBB2,3
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,2/50,31/21728,0.0023124622629413305,0.03990479751178245,0.02977178136094507,LMNA/PNPLA2,2
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,4/50,244/21728,0.002383394953745436,0.040608222882801984,0.03029658608758356,LAMA5/DUSP5/EPHB4/PHLDA3,4
WP_MAPK_CASCADE,WP_MAPK_CASCADE,2/50,33/21728,0.002618068795847952,0.04404900749014179,0.03286365304261772,MAP2K3/MAP2K7,2
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,3/50,123/21728,0.002857920849366428,0.04749088226231126,0.035431533337174435,EPHA2/PRKACA/TEAD3,3
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,2/50,35/21728,0.0029416426840529492,0.0479163244199633,0.03574894306455385,EPHA2/FOSL1,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,4/50,259/21728,0.002954721342390011,0.0479163244199633,0.03574894306455385,PVR/LMNA/CD151/RRBP1,4
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,3/50,125/21728,0.0029911553074249636,0.047929702902309544,0.0357589243519225,LDLR/DUSP5/TRPM4,3
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,4/50,262/21728,0.0030792929676388987,0.04867692866350393,0.03631640724562662,LMNA/PHLDA3/PML/MAP2K7,4
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,2/50,36/21728,0.003110115798708275,0.04867692866350393,0.03631640724562662,MAP2K3/MAP2K7,2
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,2/50,37/21728,0.0032830189827255454,0.050395917744330485,0.03759889382035762,EPHA2/EPHB4,2
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,4/50,267/21728,0.0032948296890795564,0.050395917744330485,0.03759889382035762,MAP2K3/DUSP5/PRKACA/MAP2K7,4
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,3/50,131/21728,0.003413615876849512,0.051022020626392633,0.03806601054006301,SDC4/CRIM1/EHD2,3
DORN_ADENOVIRUS_INFECTION_32HR_DN,DORN_ADENOVIRUS_INFECTION_32HR_DN,2/50,38/21728,0.003460331787360818,0.051022020626392633,0.03806601054006301,EPHA2/MAP2K3,2
STONER_ESOPHAGEAL_CARCINOGENESIS_UP,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,2/50,38/21728,0.003460331787360818,0.051022020626392633,0.03806601054006301,PVR/MAP2K3,2
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,3/50,132/21728,0.0034873892255780996,0.051022020626392633,0.03806601054006301,MAP2K3/TRIP10/MAP2K7,3
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,3/50,133/21728,0.0035621345237498788,0.05106434934229062,0.03809759073476598,ACTN4/SDC4/LMNA,3
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,3/50,134/21728,0.0036378558099911264,0.05106434934229062,0.03809759073476598,FOSL1/FURIN/NAB2,3
DORN_ADENOVIRUS_INFECTION_48HR_DN,DORN_ADENOVIRUS_INFECTION_48HR_DN,2/50,39/21728,0.003642033831248068,0.05106434934229062,0.03809759073476598,EPHA2/MAP2K3,2
REACTOME_NGF_STIMULATED_TRANSCRIPTION,REACTOME_NGF_STIMULATED_TRANSCRIPTION,2/50,39/21728,0.003642033831248068,0.05106434934229062,0.03809759073476598,FOSL1/NAB2,2
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,3/50,137/21728,0.0038709153652772567,0.053606885950414886,0.03999450160060672,EPHA2/DUSP5/PML,3
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,4/50,280/21728,0.0039030273574596278,0.053606885950414886,0.03999450160060672,SIPA1L1/LAMA5/SLC12A4/PML,4
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,4/50,283/21728,0.004053487159519182,0.05505888260224648,0.04107779307307668,CUL7/LDLR/SBNO2/PML,4
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,3/50,140/21728,0.004112900262673904,0.05505888260224648,0.04107779307307668,LMNA/NAB2/RRBP1,3
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,2/50,42/21728,0.004213272591405191,0.05505888260224648,0.04107779307307668,LDLR/DUSP5,2
DORN_ADENOVIRUS_INFECTION_24HR_DN,DORN_ADENOVIRUS_INFECTION_24HR_DN,2/50,42/21728,0.004213272591405191,0.05505888260224648,0.04107779307307668,EPHA2/MAP2K3,2
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,2/50,42/21728,0.004213272591405191,0.05505888260224648,0.04107779307307668,FURIN/ARSJ,2
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,2/50,43/21728,0.004412329119494867,0.057105721104231635,0.04260487834006177,PVR/SDC4,2
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,3/50,145/21728,0.004536319283792794,0.05815129291414382,0.04338494833822883,FURIN/SBNO2/CD151,3
PID_ERBB2_ERBB3_PATHWAY,PID_ERBB2_ERBB3_PATHWAY,2/50,44/21728,0.004615673983978643,0.05816798887858902,0.04339740470022204,PRKACA/ERBB2,2
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,3/50,146/21728,0.004624052607733302,0.05816798887858902,0.04339740470022204,LDLR/SBNO2/DUSP5,3
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,3/50,147/21728,0.004712810736013623,0.05842054477836875,0.04358582913784609,LDLR/RCE1/ALG12,3
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,2/50,45/21728,0.004823287203747071,0.05842054477836875,0.04358582913784609,ACTN4/SBNO2,2
NAKAMURA_METASTASIS_MODEL_UP,NAKAMURA_METASTASIS_MODEL_UP,2/50,45/21728,0.004823287203747071,0.05842054477836875,0.04358582913784609,FOSL1/DUSP5,2
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,2/50,46/21728,0.005035148863736314,0.05842054477836875,0.04358582913784609,MAP2K3/MAP2K7,2
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,2/50,46/21728,0.005035148863736314,0.05842054477836875,0.04358582913784609,LAMA5/ERBB2,2
PID_SYNDECAN_1_PATHWAY,PID_SYNDECAN_1_PATHWAY,2/50,46/21728,0.005035148863736314,0.05842054477836875,0.04358582913784609,LAMA5/PRKACA,2
PID_TNF_PATHWAY,PID_TNF_PATHWAY,2/50,46/21728,0.005035148863736314,0.05842054477836875,0.04358582913784609,MAP2K3/MAP2K7,2
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,2/50,46/21728,0.005035148863736314,0.05842054477836875,0.04358582913784609,LDLR/SDC4,2
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,4/50,301/21728,0.00503958548306738,0.05842054477836875,0.04358582913784609,FURIN/LAMA5/SDC4/CD151,4
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,3/50,151/21728,0.005078160281626407,0.05842054477836875,0.04358582913784609,LDLR/TRPM4/ERBB2,3
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,3/50,152/21728,0.005172093837777823,0.05899693479363517,0.044015856567707796,CD151/PHLDA3/PNPLA2,3
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,2/50,48/21728,0.005471538173220087,0.06188815446348099,0.04617290948475864,LDLR/SDC4,2
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,3/50,158/21728,0.005757754690272234,0.06458281510922022,0.04818331556596238,DHCR7/RCE1/SSH3,3
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,2/50,50/21728,0.005924683905685693,0.06483434582969873,0.048370975147831854,SDC4/XYLT2,2
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,2/50,50/21728,0.005924683905685693,0.06483434582969873,0.048370975147831854,CUL7/LMNA,2
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,2/50,50/21728,0.005924683905685693,0.06483434582969873,0.048370975147831854,MAP2K3/MAP2K7,2
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,3/50,161/21728,0.006064907446686804,0.06577764557653272,0.04907474300462362,MAP2K3/EHD2/MAP2K7,3
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,2/50,51/21728,0.006157491339259379,0.06577764557653272,0.04907474300462362,EPHA2/EPHB4,2
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,2/50,51/21728,0.006157491339259379,0.06577764557653272,0.04907474300462362,MAP2K3/MAP2K7,2
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,3/50,164/21728,0.006381717099316963,0.06763615130457191,0.050461318796091045,CRIM1/NAB2/SH2D4A,3
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,2/50,53/21728,0.006635477727259957,0.06860230814463453,0.05118213964962958,FOSL1/PHLDA3,2
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,2/50,53/21728,0.006635477727259957,0.06860230814463453,0.05118213964962958,OSBPL10/LAMA5,2
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,4/50,327/21728,0.006731258255669075,0.06860230814463453,0.05118213964962958,DUSP5/RCE1/PRKACA/ERBB2,4
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,3/50,168/21728,0.006819285947340941,0.06860230814463453,0.05118213964962958,FOSL1/LMNA/PHLDA3,3
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,2/50,54/21728,0.006880617830256807,0.06860230814463453,0.05118213964962958,ACTN4/LMNA,2
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,2/50,54/21728,0.006880617830256807,0.06860230814463453,0.05118213964962958,CRIM1/RRBP1,2
KYNG_DNA_DAMAGE_BY_UV,KYNG_DNA_DAMAGE_BY_UV,2/50,54/21728,0.006880617830256807,0.06860230814463453,0.05118213964962958,PRKACA/EPS8L1,2
PID_RAC1_PATHWAY,PID_RAC1_PATHWAY,2/50,54/21728,0.006880617830256807,0.06860230814463453,0.05118213964962958,MAP2K3/MAP2K7,2
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,2/50,55/21728,0.007129830079034245,0.0698254680282374,0.05209470282234963,SDC4/XYLT2,2
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,3/50,171/21728,0.007158926142568173,0.0698254680282374,0.05209470282234963,DHCR7/LDLR/EPS8L1,3
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,3/50,171/21728,0.007158926142568173,0.0698254680282374,0.05209470282234963,MAP2K3/DHCR7/PNPLA2,3
BIOCARTA_HIVNEF_PATHWAY,BIOCARTA_HIVNEF_PATHWAY,2/50,56/21728,0.007383095208705459,0.07047975993558545,0.052582850534565205,LMNA/MAP2K7,2
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,2/50,56/21728,0.007383095208705459,0.07047975993558545,0.052582850534565205,DHCR7/TRIP10,2
REACTOME_NEUREXINS_AND_NEUROLIGINS,REACTOME_NEUREXINS_AND_NEUROLIGINS,2/50,56/21728,0.007383095208705459,0.07047975993558545,0.052582850534565205,SIPA1L1/HOMER2,2
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,2/50,57/21728,0.0076403940183841345,0.07191587656465068,0.05365429439483596,MAP2K3/MAP2K7,2
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,2/50,57/21728,0.0076403940183841345,0.07191587656465068,0.05365429439483596,MAP2K3/MAP2K7,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,2/50,59/21728,0.008167016193123397,0.07581243997202822,0.05656140434293808,PVR/ERBB2,2
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2/50,59/21728,0.008167016193123397,0.07581243997202822,0.05656140434293808,LAMA5/SDC4,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,3/50,182/21728,0.008489530553805665,0.07826649400974264,0.05839230099733674,ACTN4/PRKACA/EPS8L1,3
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2/50,61/21728,0.008709544269228786,0.07954150333763338,0.05934354749675628,FOSL1/NAB2,2
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,3/50,184/21728,0.008746019683484206,0.07954150333763338,0.05934354749675628,FURIN/SBNO2/PML,3
ZHANG_GATA6_TARGETS_DN,ZHANG_GATA6_TARGETS_DN,2/50,63/21728,0.009267826925021554,0.08372144322871819,0.062462076202547255,DHCR7/LDLR,2
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,3/50,193/21728,0.009956464734248665,0.08934267688199135,0.06665591127349633,DHCR7/CD151/PNPLA2,3
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,3/50,195/21728,0.01023804709633073,0.09126100259378254,0.06808711697385512,PVR/FOSL1/DUSP5,3
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,4/50,371/21728,0.010384609848351411,0.0919584529992171,0.0686074639565599,FURIN/SIPA1L1/LAMA5/BCAM,4
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,2/50,69/21728,0.011035704217566814,0.09708534560029368,0.07243248588619705,MAP2K3/PRKACA,2
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,3/50,202/21728,0.0112600027192879,0.09841534844260723,0.07342476140943717,CUL7/BCAM/TRABD,3
PID_CDC42_PATHWAY,PID_CDC42_PATHWAY,2/50,70/21728,0.011343722375901978,0.09850742140621976,0.07349345430635307,MAP2K3/MAP2K7,2
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,2/50,71/21728,0.011655512020263818,0.09929315936250062,0.07407967000220976,FOSL1/PML,2
LIN_APC_TARGETS,LIN_APC_TARGETS,2/50,71/21728,0.011655512020263818,0.09929315936250062,0.07407967000220976,ACTN4/LMNA,2
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,2/50,71/21728,0.011655512020263818,0.09929315936250062,0.07407967000220976,MAP2K3/MAP2K7,2
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,4/50,388/21728,0.012083697215352412,0.10229343680417828,0.07631808767590999,CUL7/NPAS2/LMNA/ERBB2,4
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,2/50,73/21728,0.012290332777895008,0.10252069796549756,0.0764876404622544,ACTN4/ERBB2,2
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,2/50,73/21728,0.012290332777895008,0.10252069796549756,0.0764876404622544,LDLR/PRKACA,2
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,3/50,209/21728,0.012339043885891979,0.10252069796549756,0.0764876404622544,MAP2K3/LAMA5/PHLDA3,3
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,2/50,74/21728,0.01261332754922496,0.10352157854424875,0.07723436766341857,ACTN4/LMNA,2
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,2/50,74/21728,0.01261332754922496,0.10352157854424875,0.07723436766341857,MAP2K3/DUSP5,2
ODONNELL_METASTASIS_UP,ODONNELL_METASTASIS_UP,2/50,75/21728,0.012940021122352163,0.10555920261021826,0.07875457831402849,PVR/SBNO2,2
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,2/50,76/21728,0.013270395478165782,0.10760212237115145,0.08027873992498515,ACTN4/LMNA,2
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,3/50,216/21728,0.013475685908146354,0.10861241456505984,0.0810324888520115,FURIN/ARSJ/EHD2,3
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,2/50,77/21728,0.013604432657984618,0.10899741879551963,0.0813197290458479,SDC4/LMNA,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,4/50,407/21728,0.014183909443707423,0.11190950616629274,0.08349235073327856,ACTN4/CD151/RRBP1/ARSJ,4
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/50,79/21728,0.014283423956019772,0.11190950616629274,0.08349235073327856,FOSL1/NAB2,2
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,2/50,79/21728,0.014283423956019772,0.11190950616629274,0.08349235073327856,MAP2K3/MAP2K7,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,4/50,408/21728,0.014300471813226115,0.11190950616629274,0.08349235073327856,SIPA1L1/OSBPL10/EPS8L1/LRPAP1,4
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,2/50,81/21728,0.014976852549012551,0.11585542259178674,0.08643628149883834,MAP2K3/MAP2K7,2
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,2/50,81/21728,0.014976852549012551,0.11585542259178674,0.08643628149883834,ACTN4/CD151,2
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,2/50,82/21728,0.01532893657154515,0.11790142071599868,0.08796273978498692,SIPA1L1/HOMER2,2
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,2/50,83/21728,0.01568457692532419,0.11927367537562916,0.0889865381311881,SBNO2/CD151,2
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,2/50,83/21728,0.01568457692532419,0.11927367537562916,0.0889865381311881,LAMA5/SLC12A4,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,4/50,421/21728,0.015871673787637208,0.11930881585636807,0.08901275539765006,DUSP5/SLC12A4/PML/EPS8L1,4
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,2/50,84/21728,0.0160437560698385,0.11930881585636807,0.08901275539765006,EPHA2/MAP2K3,2
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,2/50,84/21728,0.0160437560698385,0.11930881585636807,0.08901275539765006,LAMA5/SDC4,2
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,2/50,84/21728,0.0160437560698385,0.11930881585636807,0.08901275539765006,FURIN/PML,2
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,3/50,232/21728,0.016292311099843665,0.1204914875845581,0.08989511156304718,EPHA2/SBNO2/DUSP5,3
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,3/50,235/21728,0.016854538222110384,0.12338826430563511,0.09205631043057473,TRIP10/DUSP5/CD151,3
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,3/50,236/21728,0.01704435226464731,0.12338826430563511,0.09205631043057473,FURIN/PML/PRKACA,3
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,2/50,87/21728,0.017142351727454506,0.12338826430563511,0.09205631043057473,ERBB2/MAP2K7,2
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,2/50,87/21728,0.017142351727454506,0.12338826430563511,0.09205631043057473,EPHA2/SBNO2,2
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2/50,87/21728,0.017142351727454506,0.12338826430563511,0.09205631043057473,SIPA1L1/HOMER2,2
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,4/50,433/21728,0.017415432097099642,0.12346073157338745,0.09211037610151845,MAP2K3/LDLR/DUSP5/EHD2,4
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,3/50,238/21728,0.01742759212402943,0.12346073157338745,0.09211037610151845,LMNA/SLC12A4/TOM1,3
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,3/50,238/21728,0.01742759212402943,0.12346073157338745,0.09211037610151845,SIPA1L1/LAMA5/SLC12A4,3
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,2/50,89/21728,0.01789212385973878,0.12608795138852563,0.09407046658688784,ACTN4/FURIN,2
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,4/50,438/21728,0.018085533748980833,0.12677495748863218,0.09458302138433963,EPHA2/MAP2K3/DUSP5/MAP2K7,4
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,3/50,242/21728,0.018208537174853302,0.12677495748863218,0.09458302138433963,EPHA2/FOSL1/SBNO2,3
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,2/50,90/21728,0.018272170693012364,0.12677495748863218,0.09458302138433963,LMNA/PRKACA,2
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,2/50,91/21728,0.018655635177431597,0.12877171768627144,0.09607274471940484,ERBB2/MAP2K7,2
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,2/50,92/21728,0.019042500240171633,0.12950508927234394,0.09661989142552291,EPHA2/EPHB4,2
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,2/50,92/21728,0.019042500240171633,0.12950508927234394,0.09661989142552291,CUL7/LMNA,2
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,4/50,445/21728,0.019050525762202154,0.12950508927234394,0.09661989142552291,MAP2K3/FOSL1/LDLR/DUSP5,4
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,3/50,249/21728,0.019621695357188086,0.13271759774258876,0.09901664835100468,MAP2K3/PRKACA/MAP2K7,3
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2/50,94/21728,0.019826364097672126,0.13276759241525712,0.0990539478878199,MAP2K3/MAP2K7,2
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,2/50,94/21728,0.019826364097672126,0.13276759241525712,0.0990539478878199,MAP2K3/MAP2K7,2
WINTER_HYPOXIA_UP,WINTER_HYPOXIA_UP,2/50,95/21728,0.020223329034641115,0.13409162995382728,0.10004177287553863,PVR/LDLR,2
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,2/50,95/21728,0.020223329034641115,0.13409162995382728,0.10004177287553863,PRKACA/PNPLA2,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,4/50,454/21728,0.020337676346528794,0.13418878609033214,0.1001142581764111,TRPM4/ERBB2/SSH3/EPS8L1,4
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,2/50,97/21728,0.02102724070983626,0.1380617853436078,0.10300378761069984,MAP2K3/MAP2K7,2
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,4/50,463/21728,0.021677607374354778,0.14000621160770435,0.10445446615605693,MAP2K3/LAMA5/PRKACA/MAP2K7,4
LIU_PROSTATE_CANCER_UP,LIU_PROSTATE_CANCER_UP,2/50,99/21728,0.02184434983118085,0.14000621160770435,0.10445446615605693,TRPM4/BCAM,2
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,2/50,99/21728,0.02184434983118085,0.14000621160770435,0.10445446615605693,LAMA5/PRKACA,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,4/50,466/21728,0.022136072962803555,0.14000621160770435,0.10445446615605693,EPHA2/FOSL1/CRIM1/ARSJ,4
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,2/50,100/21728,0.022257811788507897,0.14000621160770435,0.10445446615605693,LDLR/SDC4,2
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,2/50,100/21728,0.022257811788507897,0.14000621160770435,0.10445446615605693,DUSP5/SDC4,2
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,2/50,101/21728,0.02267452324555651,0.14000621160770435,0.10445446615605693,LDLR/DUSP5,2
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,2/50,101/21728,0.02267452324555651,0.14000621160770435,0.10445446615605693,MAP2K3/MAP2K7,2
MCCABE_HOXC6_TARGETS_UP,MCCABE_HOXC6_TARGETS_UP,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,SIPA1L1,1
REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,FURIN,1
SHIRAISHI_PLZF_TARGETS_UP,SHIRAISHI_PLZF_TARGETS_UP,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,PNKP,1
WP_LIPID_PARTICLES_COMPOSITION,WP_LIPID_PARTICLES_COMPOSITION,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,LDLR,1
WP_SARSCOV2_AND_COVID19_PATHWAY,WP_SARSCOV2_AND_COVID19_PATHWAY,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,FURIN,1
WP_VITAMIN_D_METABOLISM,WP_VITAMIN_D_METABOLISM,1/50,10/21728,0.022779613924284736,0.14000621160770435,0.10445446615605693,DHCR7,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,2/50,102/21728,0.023094467699108508,0.14129615237727297,0.10541685255956709,MAP2K3/MAP2K7,2
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,3/50,266/21728,0.02330081601109196,0.14131575103972477,0.10543147453812265,LAMA5/BCAM/SSH3,3
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,2/50,103/21728,0.023517628702004717,0.14131575103972477,0.10543147453812265,FOSL1/PML,2
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,2/50,103/21728,0.023517628702004717,0.14131575103972477,0.10543147453812265,PRKACA/BCAM,2
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2/50,103/21728,0.023517628702004717,0.14131575103972477,0.10543147453812265,MAP2K3/MAP2K7,2
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,2/50,104/21728,0.02394398986298289,0.14323826824699987,0.10686580738847101,MAP2K3/MAP2K7,2
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,2/50,106/21728,0.024806247372650473,0.14335992615054965,0.10695657272825869,FOSL1/LDLR,2
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,NAB2,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,ERBB2,1
PID_INTEGRIN4_PATHWAY,PID_INTEGRIN4_PATHWAY,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,LAMA5,1
PID_P38_GAMMA_DELTA_PATHWAY,PID_P38_GAMMA_DELTA_PATHWAY,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,MAP2K3,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,ERBB2,1
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,FURIN,1
REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,CD151,1
TAGHAVI_NEOPLASTIC_TRANSFORMATION,TAGHAVI_NEOPLASTIC_TRANSFORMATION,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,ACTN4,1
YIH_RESPONSE_TO_ARSENITE_C5,YIH_RESPONSE_TO_ARSENITE_C5,1/50,11/21728,0.02502940761172301,0.14335992615054965,0.10695657272825869,PML,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,4/50,485/21728,0.025178408898758508,0.14360228126156335,0.10713738666108662,PVR/CRIM1/HOMER2/MAP2K7,4
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,4/50,493/21728,0.026531736579645138,0.14984070359201962,0.11179168782887833,PHLDA3/BCAM/ERBB2/LRPAP1,4
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,2/50,110/21728,0.02656844924021923,0.14984070359201962,0.11179168782887833,FURIN/SDC4,2
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,3/50,281/21728,0.02683838029447337,0.14984070359201962,0.11179168782887833,EPHA2/FOSL1/LDLR,3
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,4/50,495/21728,0.02687682129346394,0.14984070359201962,0.11179168782887833,NPAS2/TRPM4/SLC12A4/ARSJ,4
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,2/50,111/21728,0.02701675721390244,0.14984070359201962,0.11179168782887833,SSH3/EPS8L1,2
LIM_MAMMARY_LUMINAL_MATURE_UP,LIM_MAMMARY_LUMINAL_MATURE_UP,2/50,111/21728,0.02701675721390244,0.14984070359201962,0.11179168782887833,LAMA5/EPS8L1,2
DAZARD_UV_RESPONSE_CLUSTER_G5,DAZARD_UV_RESPONSE_CLUSTER_G5,1/50,12/21728,0.027274125096615753,0.14984070359201962,0.11179168782887833,TOM1,1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,1/50,12/21728,0.027274125096615753,0.14984070359201962,0.11179168782887833,PRKACA,1
REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,1/50,12/21728,0.027274125096615753,0.14984070359201962,0.11179168782887833,PRKACA,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,3/50,284/21728,0.027578644002846642,0.15089778385297392,0.11258034393973342,LDLR/SDC4/TRPM4,3
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,3/50,285/21728,0.027827821574594874,0.1515474986388099,0.11306507679786085,PVR/PHLDA3/RRBP1,3
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,2/50,113/21728,0.02792257032869603,0.1515474986388099,0.11306507679786085,LAMA5/DUSP5,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,2/50,116/21728,0.029304045301696197,0.1538594924381997,0.11478998653792334,LMNA/EPHB4,2
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,3/50,291/21728,0.029348303806766486,0.1538594924381997,0.11478998653792334,LDLR/LMNA/ERBB2,3
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,ERBB2,1
KEGG_CIRCADIAN_RHYTHM_MAMMAL,KEGG_CIRCADIAN_RHYTHM_MAMMAL,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,NPAS2,1
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,ERBB2,1
REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,ERBB2,1
REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,PRKACA,1
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,ARSJ,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,RRP1,1
WP_BILE_ACIDS_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,WP_BILE_ACIDS_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,1/50,13/21728,0.029513777599155855,0.1538594924381997,0.11478998653792334,LDLR,1
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,3/50,292/21728,0.029605949882239024,0.1538594924381997,0.11478998653792334,RRP1/MAP2K3/DHCR7,3
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,3/50,293/21728,0.029864804023390375,0.1546077931364748,0.11534827141017985,SDC4/PRKACA/XYLT2,3
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,2/50,119/21728,0.030712449364076588,0.1571625327584811,0.11725428658136464,ACTN4/LDLR,2
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,2/50,119/21728,0.030712449364076588,0.1571625327584811,0.11725428658136464,LMNA/CD151,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,2/50,121/21728,0.03166613820457438,0.1571625327584811,0.11725428658136464,SDC4/PNPLA2,2
BIOCARTA_GATA3_PATHWAY,BIOCARTA_GATA3_PATHWAY,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,MAP2K3,1
BIOCARTA_RANKL_PATHWAY,BIOCARTA_RANKL_PATHWAY,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,FOSL1,1
HOEGERKORP_CD44_TARGETS_DIRECT_DN,HOEGERKORP_CD44_TARGETS_DIRECT_DN,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,BCAM,1
REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,SDC4,1
WP_DOPAMINE_METABOLISM,WP_DOPAMINE_METABOLISM,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,PRKACA,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1/50,14/21728,0.03174837631525318,0.1571625327584811,0.11725428658136464,LDLR,1
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,2/50,122/21728,0.03214736206804509,0.1571625327584811,0.11725428658136464,PRKACA/EPS8L1,2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,3/50,303/21728,0.03251967410115766,0.1571625327584811,0.11725428658136464,LAMA5/EHD2/XYLT2,3
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,2/50,124/21728,0.033118491883888136,0.1571625327584811,0.11725428658136464,SDC4/XYLT2,2
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,2/50,124/21728,0.033118491883888136,0.1571625327584811,0.11725428658136464,MAP2K3/MAP2K7,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/50,125/21728,0.03360836727537535,0.1571625327584811,0.11725428658136464,PVR/PHLDA3,2
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,3/50,307/21728,0.03361530675034417,0.1571625327584811,0.11725428658136464,PML/PRKACA/ERBB2,3
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,ERBB2,1
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,EPHA2,1
LUND_SILENCED_BY_METHYLATION,LUND_SILENCED_BY_METHYLATION,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,SDC4,1
PID_ERBB_NETWORK_PATHWAY,PID_ERBB_NETWORK_PATHWAY,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,ERBB2,1
PID_LPA4_PATHWAY,PID_LPA4_PATHWAY,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,PRKACA,1
REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA,REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,LMNA,1
REACTOME_ERBB2_REGULATES_CELL_MOTILITY,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,ERBB2,1
REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,ERBB2,1
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,TEAD3,1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,EPHA2,1
TERAMOTO_OPN_TARGETS_CLUSTER_4,TERAMOTO_OPN_TARGETS_CLUSTER_4,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,LRPAP1,1
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,SLC12A4,1
WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,DHCR7,1
WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,MAP2K7,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,LDLR,1
ZHENG_RESPONSE_TO_ARSENITE_UP,ZHENG_RESPONSE_TO_ARSENITE_UP,1/50,15/21728,0.03397793241658098,0.1571625327584811,0.11725428658136464,FOSL1,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,2/50,128/21728,0.03509505311991969,0.157697434272336,0.11765336067553653,FOSL1/LMNA,2
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,2/50,128/21728,0.03509505311991969,0.157697434272336,0.11765336067553653,OSBPL10/PNPLA2,2
KEGG_AXON_GUIDANCE,KEGG_AXON_GUIDANCE,2/50,129/21728,0.03559625130030283,0.157697434272336,0.11765336067553653,EPHA2/EPHB4,2
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,2/50,129/21728,0.03559625130030283,0.157697434272336,0.11765336067553653,ACTN4/MAP2K7,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,3/50,315/21728,0.03586407564366131,0.157697434272336,0.11765336067553653,FURIN/DUSP5/LMNA,3
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,PHLDA3,1
GHO_ATF5_TARGETS_DN,GHO_ATF5_TARGETS_DN,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,ACTN4,1
KANG_FLUOROURACIL_RESISTANCE_DN,KANG_FLUOROURACIL_RESISTANCE_DN,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,LDLR,1
PID_CIRCADIAN_PATHWAY,PID_CIRCADIAN_PATHWAY,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,NPAS2,1
PID_DNA_PK_PATHWAY,PID_DNA_PK_PATHWAY,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,PNKP,1
REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,FURIN,1
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,ERBB2,1
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,ERBB2,1
REACTOME_RAP1_SIGNALLING,REACTOME_RAP1_SIGNALLING,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,PRKACA,1
REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,ERBB2,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,PVR,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,PML,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1/50,16/21728,0.03620245705063285,0.157697434272336,0.11765336067553653,LDLR,1
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,2/50,133/21728,0.037628825698325825,0.15961716038480528,0.1190856111731479,PVR/SDC4,2
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,2/50,133/21728,0.037628825698325825,0.15961716038480528,0.1190856111731479,MAP2K3/PML,2
BIOCARTA_HCMV_PATHWAY,BIOCARTA_HCMV_PATHWAY,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,MAP2K3,1
BIOCARTA_PML_PATHWAY,BIOCARTA_PML_PATHWAY,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,PML,1
KASLER_HDAC7_TARGETS_1_DN,KASLER_HDAC7_TARGETS_1_DN,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,TRIP10,1
KEGG_STEROID_BIOSYNTHESIS,KEGG_STEROID_BIOSYNTHESIS,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,DHCR7,1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,PVR,1
NELSON_RESPONSE_TO_ANDROGEN_DN,NELSON_RESPONSE_TO_ANDROGEN_DN,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,SDC4,1
REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,ALG12,1
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,PRKACA,1
REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,PML,1
WIKMAN_ASBESTOS_LUNG_CANCER_UP,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,LRPAP1,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,LDLR,1
WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,LDLR,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,1/50,17/21728,0.03842196134077036,0.15961716038480528,0.1190856111731479,CUL7,1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,2/50,135/21728,0.03866157397724218,0.160118395610363,0.11945956785194833,CUL7/PML,2
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,3/50,325/21728,0.03878231933691722,0.16012577247696494,0.11946507151249285,LAMA5/PML/ERBB2,3
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,2/50,137/21728,0.039705139117593435,0.16174460091131543,0.12067283121091338,TRIP10/PRKACA,2
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,2/50,138/21728,0.040230941455098,0.16174460091131543,0.12067283121091338,DHCR7/LDLR,2
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,2/50,138/21728,0.040230941455098,0.16174460091131543,0.12067283121091338,FOSL1/LDLR,2
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,DUSP5,1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,DHCR7,1
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,PARVB,1
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,FURIN,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,NAB2,1
TERAMOTO_OPN_TARGETS_CLUSTER_7,TERAMOTO_OPN_TARGETS_CLUSTER_7,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,RRBP1,1
WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,MAP2K3,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,LDLR,1
WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1/50,18/21728,0.04063645638627589,0.16174460091131543,0.12067283121091338,TEAD3,1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2/50,140/21728,0.04129051299557801,0.16174460091131543,0.12067283121091338,FURIN/LAMA5,2
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,2/50,140/21728,0.04129051299557801,0.16174460091131543,0.12067283121091338,EPHB4/SH2D4A,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,DUSP5,1
JEON_SMAD6_TARGETS_DN,JEON_SMAD6_TARGETS_DN,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,DHCR7,1
KANG_DOXORUBICIN_RESISTANCE_DN,KANG_DOXORUBICIN_RESISTANCE_DN,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,CRIM1,1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,HOMER2,1
PID_EPHA2_FWD_PATHWAY,PID_EPHA2_FWD_PATHWAY,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,EPHA2,1
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,FURIN,1
REACTOME_EPHRIN_SIGNALING,REACTOME_EPHRIN_SIGNALING,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,EPHB4,1
REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,LMNA,1
REACTOME_LDL_CLEARANCE,REACTOME_LDL_CLEARANCE,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,LDLR,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,PRKACA,1
VISALA_AGING_LYMPHOCYTE_DN,VISALA_AGING_LYMPHOCYTE_DN,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,SDC4,1
WENG_POR_TARGETS_GLOBAL_UP,WENG_POR_TARGETS_GLOBAL_UP,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,DHCR7,1
WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,TEAD3,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,XYLT2,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/50,19/21728,0.04284595326240148,0.16174460091131543,0.12067283121091338,LDLR,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,2/50,143/21728,0.04289957096979168,0.16174460091131543,0.12067283121091338,SDC4/ALG12,2
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,2/50,143/21728,0.04289957096979168,0.16174460091131543,0.12067283121091338,FOSL1/CRIM1,2
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,2/50,144/21728,0.04344111975461853,0.16332890276457135,0.12185483165511933,TRPM4/PRKACA,2
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,2/50,145/21728,0.043985242838126645,0.1644559357225513,0.12269567739056382,TRIP10/LDLR,2
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,2/50,145/21728,0.043985242838126645,0.1644559357225513,0.12269567739056382,MAP2K3/DUSP5,2
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,2/50,146/21728,0.044531926035770955,0.1660387048314341,0.12387653429982651,DHCR7/LDLR,2
REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,1/50,20/21728,0.04505046302042259,0.16613129650818853,0.12394561419317422,SDC4,1
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,1/50,20/21728,0.04505046302042259,0.16613129650818853,0.12394561419317422,PRKACA,1
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,1/50,20/21728,0.04505046302042259,0.16613129650818853,0.12394561419317422,ERBB2,1
WEBER_METHYLATED_HCP_IN_SPERM_UP,WEBER_METHYLATED_HCP_IN_SPERM_UP,1/50,20/21728,0.04505046302042259,0.16613129650818853,0.12394561419317422,TRPM4,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,2/50,149/21728,0.04618719520689617,0.16888640708265654,0.12600112016646153,LAMA5/SDC4,2
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,2/50,150/21728,0.046743977999725454,0.16888640708265654,0.12600112016646153,FURIN/DUSP5,2
HU_ANGIOGENESIS_UP,HU_ANGIOGENESIS_UP,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,SIPA1L1,1
JACKSON_DNMT1_TARGETS_DN,JACKSON_DNMT1_TARGETS_DN,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,LDLR,1
NUMATA_CSF3_SIGNALING_VIA_STAT3,NUMATA_CSF3_SIGNALING_VIA_STAT3,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,MAP2K7,1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,MAP2K3,1
REACTOME_CD209_DC_SIGN_SIGNALING,REACTOME_CD209_DC_SIGN_SIGNALING,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,PRKACA,1
STEGER_ADIPOGENESIS_UP,STEGER_ADIPOGENESIS_UP,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,PNPLA2,1
VERRECCHIA_RESPONSE_TO_TGFB1_C5,VERRECCHIA_RESPONSE_TO_TGFB1_C5,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,EPHA2,1
WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,1/50,21/21728,0.04724999668768681,0.16888640708265654,0.12600112016646153,PRKACA,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,2/50,151/21728,0.047303250720773786,0.16888640708265654,0.12600112016646153,FOSL1/PRKACA,2
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,2/50,151/21728,0.047303250720773786,0.16888640708265654,0.12600112016646153,ACTN4/HOMER2,2
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,2/50,153/21728,0.04842921043267003,0.17018990119933836,0.12697361831873683,DHCR7/LDLR,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/50,154/21728,0.048995869787077234,0.17018990119933836,0.12697361831873683,MAP2K3/MAP2K7,2
BIOCARTA_CASPASE_PATHWAY,BIOCARTA_CASPASE_PATHWAY,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,LMNA,1
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,EPHA2,1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,XYLT2,1
MAHADEVAN_IMATINIB_RESISTANCE_UP,MAHADEVAN_IMATINIB_RESISTANCE_UP,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,CRIM1,1
PID_HEDGEHOG_2PATHWAY,PID_HEDGEHOG_2PATHWAY,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,LRPAP1,1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,OSBPL10,1
REACTOME_HS_GAG_DEGRADATION,REACTOME_HS_GAG_DEGRADATION,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,SDC4,1
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,MAP2K7,1
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,ERBB2,1
WENG_POR_TARGETS_LIVER_DN,WENG_POR_TARGETS_LIVER_DN,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,SDC4,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,LDLR,1
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,1/50,22/21728,0.049444565267666496,0.17018990119933836,0.12697361831873683,MAP2K3,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,2/50,155/21728,0.04956496379653836,0.17018990119933836,0.12697361831873683,MAP2K3/MAP2K7,2
BIOCARTA_HER2_PATHWAY,BIOCARTA_HER2_PATHWAY,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,ERBB2,1
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,MAP2K3,1
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,ERBB2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,PML,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,TOM1,1
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,MAP2K3,1
REACTOME_NEPHRIN_FAMILY_INTERACTIONS,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,ACTN4,1
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,DUSP5,1
REACTOME_SIGNALING_BY_NODAL,REACTOME_SIGNALING_BY_NODAL,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,FURIN,1
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,OSBPL10,1
WP_ESTROGEN_SIGNALING_PATHWAY,WP_ESTROGEN_SIGNALING_PATHWAY,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,PRKACA,1
WP_HIPPOYAP_SIGNALING_PATHWAY,WP_HIPPOYAP_SIGNALING_PATHWAY,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,TEAD3,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,LMNA,1
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,MAP2K3,1
WU_HBX_TARGETS_2_UP,WU_HBX_TARGETS_2_UP,1/50,23/21728,0.051634179740006725,0.17076070253083306,0.12739947619802516,MAP2K3,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,3/50,367/21728,0.052317825054000275,0.17125336531332908,0.1277670372322796,TRIP10/EPHB4/PML,3
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,2/50,160/21728,0.0524464759172522,0.17125336531332908,0.1277670372322796,RRBP1/BCAM,2
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,2/50,160/21728,0.0524464759172522,0.17125336531332908,0.1277670372322796,RRP1/MAP2K3,2
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,3/50,371/21728,0.05371250841302819,0.17125336531332908,0.1277670372322796,DHCR7/LDLR/CD151,3
BIOCARTA_STRESS_PATHWAY,BIOCARTA_STRESS_PATHWAY,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,MAP2K3,1
BIOCARTA_TFF_PATHWAY,BIOCARTA_TFF_PATHWAY,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,ERBB2,1
HANSON_HRAS_SIGNALING_VIA_NFKB,HANSON_HRAS_SIGNALING_VIA_NFKB,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,PVR,1
HASLINGER_B_CLL_WITH_13Q14_DELETION,HASLINGER_B_CLL_WITH_13Q14_DELETION,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,LDLR,1
HORTON_SREBF_TARGETS,HORTON_SREBF_TARGETS,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,LDLR,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,CRIM1,1
REACTOME_DARPP_32_EVENTS,REACTOME_DARPP_32_EVENTS,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,PRKACA,1
REACTOME_RAS_PROCESSING,REACTOME_RAS_PROCESSING,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,RCE1,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,ERBB2,1
REACTOME_TRIGLYCERIDE_CATABOLISM,REACTOME_TRIGLYCERIDE_CATABOLISM,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,PRKACA,1
VALK_AML_WITH_11Q23_REARRANGED,VALK_AML_WITH_11Q23_REARRANGED,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,TRPM4,1
WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,1/50,24/21728,0.053818851060578154,0.17125336531332908,0.1277670372322796,PNPLA2,1
BIOCARTA_TOLL_PATHWAY,BIOCARTA_TOLL_PATHWAY,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,MAP2K3,1
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,PRKACA,1
PID_MYC_PATHWAY,PID_MYC_PATHWAY,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,PML,1
REACTOME_CHOLESTEROL_BIOSYNTHESIS,REACTOME_CHOLESTEROL_BIOSYNTHESIS,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,DHCR7,1
REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,LMNA,1
VALK_AML_CLUSTER_8,VALK_AML_CLUSTER_8,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,BCAM,1
VALK_AML_WITH_EVI1,VALK_AML_WITH_EVI1,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,CRIM1,1
WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,ALG12,1
WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1/50,25/21728,0.05599859016152564,0.17447708879030907,0.13017216134038856,MAP2K3,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,3/50,378/21728,0.056196407667900676,0.17468906402077208,0.13033030974882034,RRP1/SBNO2/ERBB2,3
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,2/50,167/21728,0.05657905663299055,0.17502296137116816,0.13057942062101702,MAP2K3/FOSL1,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,2/50,168/21728,0.057178571942456236,0.17502296137116816,0.13057942062101702,SLC12A4/XYLT2,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,3/50,383/21728,0.05800403000821495,0.17502296137116816,0.13057942062101702,OSBPL10/EHD2/TOM1,3
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,XYLT2,1
PID_IL3_PATHWAY,PID_IL3_PATHWAY,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,PRKACA,1
PID_INSULIN_GLUCOSE_PATHWAY,PID_INSULIN_GLUCOSE_PATHWAY,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,TRIP10,1
PID_P38_MKK3_6PATHWAY,PID_P38_MKK3_6PATHWAY,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,MAP2K3,1
PID_VEGFR1_PATHWAY,PID_VEGFR1_PATHWAY,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,PRKACA,1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,ERBB2,1
TERAMOTO_OPN_TARGETS_CLUSTER_6,TERAMOTO_OPN_TARGETS_CLUSTER_6,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,ACTN4,1
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,SDC4,1
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,PNPLA2,1
WP_TRIACYLGLYCERIDE_SYNTHESIS,WP_TRIACYLGLYCERIDE_SYNTHESIS,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,PNPLA2,1
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,1/50,26/21728,0.058173407951320866,0.17502296137116816,0.13057942062101702,PML,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,2/50,170/21728,0.05838433109632578,0.17502296137116816,0.13057942062101702,FURIN/DUSP5,2
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2/50,170/21728,0.05838433109632578,0.17502296137116816,0.13057942062101702,PRKACA/EHD2,2
BIOCARTA_PYK2_PATHWAY,BIOCARTA_PYK2_PATHWAY,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,MAP2K3,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,LDLR,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,PARVB,1
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,NPAS2,1
REACTOME_SYNDECAN_INTERACTIONS,REACTOME_SYNDECAN_INTERACTIONS,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,SDC4,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_7,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,PML,1
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,PNPLA2,1
WESTON_VEGFA_TARGETS_12HR,WESTON_VEGFA_TARGETS_12HR,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,SDC4,1
WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING_PATHWAY,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING_PATHWAY,1/50,27/21728,0.06034331531480952,0.17734083496448388,0.13230871710027187,PRKACA,1
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,ERBB2,1
DORN_ADENOVIRUS_INFECTION_12HR_UP,DORN_ADENOVIRUS_INFECTION_12HR_UP,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,EPHA2,1
PID_LIS1_PATHWAY,PID_LIS1_PATHWAY,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,LRPAP1,1
REACTOME_TRP_CHANNELS,REACTOME_TRP_CHANNELS,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,TRPM4,1
WP_7OXOC_AND_7BETAHC_PATHWAYS,WP_7OXOC_AND_7BETAHC_PATHWAYS,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,DHCR7,1
WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1/50,28/21728,0.06250832311326404,0.1813280235139082,0.13528343976872484,PVR,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,2/50,178/21728,0.06329518406072694,0.18200220196881925,0.1357864242420064,PRKACA/ERBB2,2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,2/50,178/21728,0.06329518406072694,0.18200220196881925,0.1357864242420064,DUSP5/PHLDA3,2
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,3/50,400/21728,0.06435515153649127,0.18200220196881925,0.1357864242420064,DHCR7/NAB2/TOM1,3
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,DUSP5,1
BIOCARTA_DEATH_PATHWAY,BIOCARTA_DEATH_PATHWAY,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,LMNA,1
BIOCARTA_TNFR1_PATHWAY,BIOCARTA_TNFR1_PATHWAY,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,LMNA,1
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,ERBB2,1
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,NAB2,1
REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,EPHA2,1
VALK_AML_CLUSTER_16,VALK_AML_CLUSTER_16,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,TRPM4,1
WP_CANNABINOID_RECEPTOR_SIGNALING,WP_CANNABINOID_RECEPTOR_SIGNALING,1/50,29/21728,0.06466844218443202,0.18200220196881925,0.1357864242420064,PRKACA,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,2/50,181/21728,0.06517206453053147,0.18200220196881925,0.1357864242420064,LMNA/NAB2,2
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,2/50,181/21728,0.06517206453053147,0.18200220196881925,0.1357864242420064,LDLR/EHD2,2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,EPHA2,1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,ACTN4,1
BIOCARTA_FAS_PATHWAY,BIOCARTA_FAS_PATHWAY,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,LMNA,1
CHOW_RASSF1_TARGETS_DN,CHOW_RASSF1_TARGETS_DN,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,LRPAP1,1
DORSEY_GAB2_TARGETS,DORSEY_GAB2_TARGETS,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,DUSP5,1
PID_EPHRINB_REV_PATHWAY,PID_EPHRINB_REV_PATHWAY,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,EPHB4,1
PID_NECTIN_PATHWAY,PID_NECTIN_PATHWAY,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,PVR,1
PID_P38_ALPHA_BETA_PATHWAY,PID_P38_ALPHA_BETA_PATHWAY,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,MAP2K3,1
PID_RETINOIC_ACID_PATHWAY,PID_RETINOIC_ACID_PATHWAY,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,PRKACA,1
REACTOME_LAMININ_INTERACTIONS,REACTOME_LAMININ_INTERACTIONS,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,LAMA5,1
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,LAMA5,1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,PML,1
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,FOSL1,1
TIEN_INTESTINE_PROBIOTICS_2HR_UP,TIEN_INTESTINE_PROBIOTICS_2HR_UP,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,EPHB4,1
WIKMAN_ASBESTOS_LUNG_CANCER_DN,WIKMAN_ASBESTOS_LUNG_CANCER_DN,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,PRKACA,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,ERBB2,1
WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1/50,30/21728,0.06682368334258537,0.18200220196881925,0.1357864242420064,PRKACA,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,2/50,184/21728,0.06706767620842076,0.18200220196881925,0.1357864242420064,RRBP1/BCAM,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,2/50,184/21728,0.06706767620842076,0.18200220196881925,0.1357864242420064,LMNA/LRPAP1,2
WP_RAS_SIGNALING,WP_RAS_SIGNALING,2/50,185/21728,0.06770365124624395,0.1833583794314776,0.13679822787020382,EPHA2/PRKACA,2
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,2/50,186/21728,0.06834165795174907,0.18347644512166036,0.13688631316654726,MAP2K3/HOMER2,2
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,3/50,411/21728,0.06863069001951826,0.18347644512166036,0.13688631316654726,SIPA1L1/PRKACA/HOMER2,3
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,MAP2K3,1
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,ERBB2,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,FURIN,1
KIM_TIAL1_TARGETS,KIM_TIAL1_TARGETS,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,LAMA5,1
PID_AURORA_A_PATHWAY,PID_AURORA_A_PATHWAY,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,PRKACA,1
REACTOME_HS_GAG_BIOSYNTHESIS,REACTOME_HS_GAG_BIOSYNTHESIS,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,SDC4,1
WP_BASE_EXCISION_REPAIR,WP_BASE_EXCISION_REPAIR,1/50,31/21728,0.06897405737857365,0.18347644512166036,0.13688631316654726,PNKP,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,2/50,189/21728,0.07026774552140895,0.18461642463189973,0.13773681793918227,LDLR/SDC4,2
CAFFAREL_RESPONSE_TO_THC_DN,CAFFAREL_RESPONSE_TO_THC_DN,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,DHCR7,1
DORSAM_HOXA9_TARGETS_DN,DORSAM_HOXA9_TARGETS_DN,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,SDC4,1
FIRESTEIN_CTNNB1_PATHWAY,FIRESTEIN_CTNNB1_PATHWAY,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,EPHA2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,LDLR,1
PID_SYNDECAN_4_PATHWAY,PID_SYNDECAN_4_PATHWAY,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,SDC4,1
REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,PRKACA,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1/50,32/21728,0.07111957505986954,0.18461642463189973,0.13773681793918227,FURIN,1
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PVR,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PARVB,1
DORN_ADENOVIRUS_INFECTION_12HR_DN,DORN_ADENOVIRUS_INFECTION_12HR_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,MAP2K3,1
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,MAP2K3,1
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,CUL7,1
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,EPHA2,1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,SDC4,1
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PRKACA,1
PID_SYNDECAN_2_PATHWAY,PID_SYNDECAN_2_PATHWAY,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PRKACA,1
REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,FURIN,1
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PVR,1
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,PRKACA,1
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,LDLR,1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,LRPAP1,1
VALK_AML_CLUSTER_10,VALK_AML_CLUSTER_10,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,CRIM1,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,LAMA5,1
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,LAMA5,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,ERBB2,1
WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,LDLR,1
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,1/50,33/21728,0.07326024713061985,0.18461642463189973,0.13773681793918227,DUSP5,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,3/50,423/21728,0.0734402224734663,0.18461642463189973,0.13773681793918227,TRPM4/RRBP1/TRABD,3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,2/50,194/21728,0.0735173875205782,0.18461642463189973,0.13773681793918227,SBNO2/ARSJ,2
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,2/50,195/21728,0.07417313198093303,0.18474545416428378,0.13783308303177189,CRIM1/EHD2,2
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,2/50,196/21728,0.07483078728858389,0.18474545416428378,0.13783308303177189,LAMA5/CRIM1,2
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,2/50,196/21728,0.07483078728858389,0.18474545416428378,0.13783308303177189,MAP2K3/MAP2K7,2
BIOCARTA_FMLP_PATHWAY,BIOCARTA_FMLP_PATHWAY,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,MAP2K3,1
LUI_TARGETS_OF_PAX8_PPARG_FUSION,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,SDC4,1
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,CRIM1,1
PID_EPHA_FWDPATHWAY,PID_EPHA_FWDPATHWAY,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,EPHA2,1
PID_MAPK_TRK_PATHWAY,PID_MAPK_TRK_PATHWAY,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,MAP2K3,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,FURIN,1
SIG_CD40PATHWAYMAP,SIG_CD40PATHWAYMAP,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,MAP2K7,1
VANTVEER_BREAST_CANCER_BRCA1_UP,VANTVEER_BREAST_CANCER_BRCA1_UP,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,RRP1,1
WP_FATTY_ACID_BETAOXIDATION,WP_FATTY_ACID_BETAOXIDATION,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,PNPLA2,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/50,34/21728,0.07539608431169742,0.18474545416428378,0.13783308303177189,MAP2K3,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/50,197/21728,0.07549034159758995,0.18474545416428378,0.13783308303177189,NAB2/ERBB2,2
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,2/50,198/21728,0.07615178310442873,0.1851027269032521,0.1380996335854403,RRP1/LMNA,2
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,3/50,432/21728,0.07714490088395488,0.1851027269032521,0.1380996335854403,LMNA/RRBP1/ERBB2,3
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,LDLR,1
JAZAG_TGFB1_SIGNALING_DN,JAZAG_TGFB1_SIGNALING_DN,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,NAB2,1
KEGG_PRION_DISEASES,KEGG_PRION_DISEASES,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,PRKACA,1
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,EPHA2,1
PID_HIV_NEF_PATHWAY,PID_HIV_NEF_PATHWAY,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,MAP2K7,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,PRKACA,1
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,ACTN4,1
ROZANOV_MMP14_TARGETS_DN,ROZANOV_MMP14_TARGETS_DN,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,SDC4,1
WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,LAMA5,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/50,35/21728,0.07752709730074547,0.1851027269032521,0.1380996335854403,MAP2K3,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,3/50,433/21728,0.07756161810804918,0.1851027269032521,0.1380996335854403,DHCR7/LDLR/PNPLA2,3
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,3/50,433/21728,0.07756161810804918,0.1851027269032521,0.1380996335854403,SIPA1L1/TRPM4/HOMER2,3
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,3/50,434/21728,0.07797934505408041,0.1857702627306057,0.13859766219206843,PVR/DUSP5/TRPM4,3
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,3/50,437/21728,0.07923856345276666,0.18581167669917625,0.13862855992102463,SDC4/CRIM1/BCAM,3
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,2/50,203/21728,0.07948688843626928,0.18581167669917625,0.13862855992102463,TRPM4/ERBB2,2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,CUL7,1
CUI_TCF21_TARGETS_UP,CUI_TCF21_TARGETS_UP,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,HOMER2,1
HOUSTIS_ROS,HOUSTIS_ROS,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,SDC4,1
KANG_GLIS3_TARGETS,KANG_GLIS3_TARGETS,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,LDLR,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,SBNO2,1
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,PRKACA,1
RIZ_ERYTHROID_DIFFERENTIATION_12HR,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,NAB2,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,DUSP5,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,ERBB2,1
WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,1/50,36/21728,0.07965329677223232,0.18581167669917625,0.13862855992102463,TEAD3,1
GENTILE_UV_RESPONSE_CLUSTER_D7,GENTILE_UV_RESPONSE_CLUSTER_D7,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,TRIP10,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,CD151,1
PID_FRA_PATHWAY,PID_FRA_PATHWAY,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,FOSL1,1
REACTOME_CA_DEPENDENT_EVENTS,REACTOME_CA_DEPENDENT_EVENTS,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,PRKACA,1
REACTOME_RHOV_GTPASE_CYCLE,REACTOME_RHOV_GTPASE_CYCLE,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,EPHA2,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/50,37/21728,0.08177469337749643,0.18851032848830965,0.1406419436754887,EPHB4,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,2/50,207/21728,0.08218775382276915,0.18851032848830965,0.1406419436754887,PARVB/TRABD,2
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,2/50,207/21728,0.08218775382276915,0.18851032848830965,0.1406419436754887,FOSL1/SDC4,2
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,2/50,207/21728,0.08218775382276915,0.18851032848830965,0.1406419436754887,NPAS2/PML,2
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,2/50,209/21728,0.08354886101331015,0.18851032848830965,0.1406419436754887,SSH3/EPS8L1,2
APPIERTO_RESPONSE_TO_FENRETINIDE_UP,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,SDC4,1
BURTON_ADIPOGENESIS_PEAK_AT_8HR,BURTON_ADIPOGENESIS_PEAK_AT_8HR,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,FOSL1,1
GENTILE_UV_RESPONSE_CLUSTER_D2,GENTILE_UV_RESPONSE_CLUSTER_D2,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,DUSP5,1
PID_ERBB4_PATHWAY,PID_ERBB4_PATHWAY,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,ERBB2,1
PID_FAS_PATHWAY,PID_FAS_PATHWAY,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,MAP2K7,1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,LMNA,1
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,PNKP,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,ERBB2,1
REACTOME_TRIGLYCERIDE_METABOLISM,REACTOME_TRIGLYCERIDE_METABOLISM,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,PRKACA,1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,SDC4,1
WP_SLEEP_REGULATION,WP_SLEEP_REGULATION,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,NPAS2,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/50,38/21728,0.08389129774479753,0.18851032848830965,0.1406419436754887,ACTN4,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,3/50,450/21728,0.0847985877486008,0.18986417424753727,0.14165200768917696,CUL7/SBNO2/ERBB2,3
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,2/50,211/21728,0.08491696351932944,0.18986417424753727,0.14165200768917696,OSBPL10/PNPLA2,2
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,2/50,211/21728,0.08491696351932944,0.18986417424753727,0.14165200768917696,FURIN/PML,2
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,3/50,451/21728,0.08523315782902764,0.19025510852051608,0.14194367211118508,NPAS2/FOSL1/DUSP5,3
BIOCARTA_FCER1_PATHWAY,BIOCARTA_FCER1_PATHWAY,1/50,39/21728,0.0860031204793642,0.1907087317384254,0.14228210688860393,MAP2K7,1
ONGUSAHA_TP53_TARGETS,ONGUSAHA_TP53_TARGETS,1/50,39/21728,0.0860031204793642,0.1907087317384254,0.14228210688860393,PHLDA3,1
PID_RET_PATHWAY,PID_RET_PATHWAY,1/50,39/21728,0.0860031204793642,0.1907087317384254,0.14228210688860393,PRKACA,1
REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,1/50,39/21728,0.0860031204793642,0.1907087317384254,0.14228210688860393,PML,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,2/50,213/21728,0.0862919713958983,0.19072084318370955,0.14229114287734335,CRIM1/BCAM,2
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,2/50,213/21728,0.0862919713958983,0.19072084318370955,0.14229114287734335,ACTN4/SSH3,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,3/50,456/21728,0.08742053716706989,0.19221441123500432,0.14340544953327142,EPHA2/FOSL1/TRIP10,3
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,3/50,456/21728,0.08742053716706989,0.19221441123500432,0.14340544953327142,MAP2K3/DUSP5/KLHDC4,3
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,EPHA2,1
NABA_BASEMENT_MEMBRANES,NABA_BASEMENT_MEMBRANES,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,LAMA5,1
PID_EPHB_FWD_PATHWAY,PID_EPHB_FWD_PATHWAY,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,EPHB4,1
REACTOME_RET_SIGNALING,REACTOME_RET_SIGNALING,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,PRKACA,1
REACTOME_RHOU_GTPASE_CYCLE,REACTOME_RHOU_GTPASE_CYCLE,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,EPHA2,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/50,40/21728,0.08811017216344552,0.19221441123500432,0.14340544953327142,LMNA,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,3/50,461/21728,0.08963193061870854,0.19335346445486332,0.14425526322823148,SDC4/NAB2/RRBP1,3
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,PRKACA,1
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,ACTN4,1
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,EPHA2,1
REACTOME_DAG_AND_IP3_SIGNALING,REACTOME_DAG_AND_IP3_SIGNALING,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,PRKACA,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,SDC4,1
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,LAMA5,1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,NAB2,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,ERBB2,1
WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,EPHB4,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/50,41/21728,0.09021246335635524,0.19335346445486332,0.14425526322823148,PML,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,3/50,463/21728,0.09052315017864027,0.19371090642360858,0.1445219400391981,RRP1/FURIN/CRIM1,3
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,2/50,220/21728,0.09115759535824813,0.1941540061383662,0.1448525235442257,SIPA1L1/LDLR,2
CHEN_HOXA5_TARGETS_9HR_DN,CHEN_HOXA5_TARGETS_9HR_DN,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,EHD2,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,ERBB2,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,CRIM1,1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,DHCR7,1
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,EPHB4,1
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,PRKACA,1
REACTOME_RND1_GTPASE_CYCLE,REACTOME_RND1_GTPASE_CYCLE,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,EPHA2,1
REACTOME_RND3_GTPASE_CYCLE,REACTOME_RND3_GTPASE_CYCLE,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,EPHA2,1
WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,1/50,42/21728,0.09231000459452476,0.1941540061383662,0.1448525235442257,PRKACA,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,3/50,467/21728,0.09231691227975808,0.1941540061383662,0.1448525235442257,ACTN4/SBNO2/PARVB,3
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,2/50,223/21728,0.09326748847951163,0.19554211759100104,0.14588815217159223,FURIN/PRKACA,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,2/50,223/21728,0.09326748847951163,0.19554211759100104,0.14588815217159223,MAP2K3/SDC4,2
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,2/50,224/21728,0.09397399010313846,0.19578763852546258,0.14607132803104037,EPHA2/PRKACA,2
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,2/50,224/21728,0.09397399010313846,0.19578763852546258,0.14607132803104037,RRP1/EPHA2,2
PID_CXCR3_PATHWAY,PID_CXCR3_PATHWAY,1/50,43/21728,0.09440280639154919,0.19578763852546258,0.14607132803104037,MAP2K3,1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1/50,43/21728,0.09440280639154919,0.19578763852546258,0.14607132803104037,DUSP5,1
REACTOME_RND2_GTPASE_CYCLE,REACTOME_RND2_GTPASE_CYCLE,1/50,43/21728,0.09440280639154919,0.19578763852546258,0.14607132803104037,EPHA2,1
REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,1/50,43/21728,0.09440280639154919,0.19578763852546258,0.14607132803104037,PRKACA,1
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,1/50,43/21728,0.09440280639154919,0.19578763852546258,0.14607132803104037,TRPM4,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,2/50,226/21728,0.09539173493771173,0.1973810386849044,0.147260116450613,NPAS2/PML,2
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,LAMA5,1
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,PRKACA,1
NAKAMURA_METASTASIS_MODEL_DN,NAKAMURA_METASTASIS_MODEL_DN,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,LDLR,1
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,TRIP10,1
WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,LMNA,1
WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,PRKACA,1
WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,EPHB4,1
WP_VASOPRESSINREGULATED_WATER_REABSORPTION,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1/50,44/21728,0.09649087923823707,0.1973810386849044,0.147260116450613,PRKACA,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,2/50,230/21728,0.09824589367400327,0.19832723233060726,0.1479660433591924,FOSL1/LMNA,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,EPHB4,1
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,PNPLA2,1
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,SDC4,1
PID_ILK_PATHWAY,PID_ILK_PATHWAY,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,PARVB,1
PID_NFAT_TFPATHWAY,PID_NFAT_TFPATHWAY,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,FOSL1,1
PID_RHOA_PATHWAY,PID_RHOA_PATHWAY,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,MAP2K3,1
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,FURIN,1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,ARSJ,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,PVR,1
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,1/50,45/21728,0.09857423360265694,0.19832723233060726,0.1479660433591924,DUSP5,1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,EPHA2,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,MAP2K3,1
HOLLERN_MICROACINAR_BREAST_TUMOR_UP,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,HOMER2,1
KEGG_N_GLYCAN_BIOSYNTHESIS,KEGG_N_GLYCAN_BIOSYNTHESIS,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,ALG12,1
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,PML,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,BCAM,1
NAKAMURA_CANCER_MICROENVIRONMENT_DN,NAKAMURA_CANCER_MICROENVIRONMENT_DN,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,HOMER2,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_3,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,TRABD,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/50,46/21728,0.10065287993018845,0.19982120410919418,0.14908065122403324,DHCR7,1
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/50,47/21728,0.10272682864356808,0.20244555103110196,0.1510385983292964,LDLR,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/50,47/21728,0.10272682864356808,0.20244555103110196,0.1510385983292964,FOSL1,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,1/50,47/21728,0.10272682864356808,0.20244555103110196,0.1510385983292964,CD151,1
PID_LKB1_PATHWAY,PID_LKB1_PATHWAY,1/50,47/21728,0.10272682864356808,0.20244555103110196,0.1510385983292964,PRKACA,1
REACTOME_SENSORY_PERCEPTION_OF_TASTE,REACTOME_SENSORY_PERCEPTION_OF_TASTE,1/50,47/21728,0.10272682864356808,0.20244555103110196,0.1510385983292964,TRPM4,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,3/50,491/21728,0.10338892644791839,0.2032500537930738,0.15163881388800532,EPHA2/CRIM1/EHD2,3
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,2/50,239/21728,0.10475570204591851,0.2032500537930738,0.15163881388800532,DHCR7/SDC4,2
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,SDC4,1
LEE_CALORIE_RESTRICTION_MUSCLE_DN,LEE_CALORIE_RESTRICTION_MUSCLE_DN,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,TEAD3,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,ERBB2,1
PID_HEDGEHOG_GLI_PATHWAY,PID_HEDGEHOG_GLI_PATHWAY,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,PRKACA,1
REACTOME_HEME_SIGNALING,REACTOME_HEME_SIGNALING,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,NPAS2,1
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,PRKACA,1
SU_PANCREAS,SU_PANCREAS,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,PML,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,DHCR7,1
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1/50,48/21728,0.104796090142937,0.2032500537930738,0.15163881388800532,TEAD3,1
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,1/50,49/21728,0.10686067480589145,0.20577177151463502,0.15352019240241016,MAP2K3,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1/50,49/21728,0.10686067480589145,0.20577177151463502,0.15352019240241016,SDC4,1
MILI_PSEUDOPODIA,MILI_PSEUDOPODIA,1/50,49/21728,0.10686067480589145,0.20577177151463502,0.15352019240241016,MAP2K7,1
WP_IL3_SIGNALING_PATHWAY,WP_IL3_SIGNALING_PATHWAY,1/50,49/21728,0.10686067480589145,0.20577177151463502,0.15352019240241016,PRKACA,1
WP_MICROTUBULE_CYTOSKELETON_REGULATION,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1/50,49/21728,0.10686067480589145,0.20577177151463502,0.15352019240241016,PRKACA,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,2/50,243/21728,0.1076865246861704,0.2070658031822648,0.1544856309031678,SIPA1L1/PRKACA,2
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,CUL7,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,LDLR,1
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,BCAM,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,ERBB2,1
WESTON_VEGFA_TARGETS_6HR,WESTON_VEGFA_TARGETS_6HR,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,SDC4,1
ZHU_CMV_8_HR_DN,ZHU_CMV_8_HR_DN,1/50,50/21728,0.10892059298752843,0.2076588075937865,0.15492805383942468,LMNA,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,2/50,245/21728,0.10916030391738525,0.20782145554851564,0.15504940063602404,FOSL1/TOM1,2
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,2/50,246/21728,0.10989925066620045,0.20893275621003643,0.15587850897346897,SDC4/ALG12,2
MORI_IMMATURE_B_LYMPHOCYTE_UP,MORI_IMMATURE_B_LYMPHOCYTE_UP,1/50,51/21728,0.11097585502049412,0.21038521247547193,0.156962143349965,PML,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/50,51/21728,0.11097585502049412,0.21038521247547193,0.156962143349965,LMNA,1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,CRIM1,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,ERBB2,1
KEGG_TASTE_TRANSDUCTION,KEGG_TASTE_TRANSDUCTION,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,PRKACA,1
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,KLHDC4,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,NAB2,1
REACTOME_APOPTOTIC_EXECUTION_PHASE,REACTOME_APOPTOTIC_EXECUTION_PHASE,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,LMNA,1
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,1/50,52/21728,0.11302647121503062,0.21218079533532944,0.15830177426284847,PRKACA,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,2/50,251/21728,0.11361416191651955,0.21298699434489596,0.1589032553413864,CD151/ERBB2,2
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,1/50,53/21728,0.11507245185902626,0.21400165639298663,0.15966026448651696,MAP2K3,1
MARTIN_VIRAL_GPCR_SIGNALING_DN,MARTIN_VIRAL_GPCR_SIGNALING_DN,1/50,53/21728,0.11507245185902626,0.21400165639298663,0.15966026448651696,FOSL1,1
PID_NFAT_3PATHWAY,PID_NFAT_3PATHWAY,1/50,53/21728,0.11507245185902626,0.21400165639298663,0.15966026448651696,PRKACA,1
REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,1/50,53/21728,0.11507245185902626,0.21400165639298663,0.15966026448651696,LMNA,1
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,1/50,53/21728,0.11507245185902626,0.21400165639298663,0.15966026448651696,LDLR,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,2/50,253/21728,0.11510936049667334,0.21400165639298663,0.15966026448651696,FOSL1/DUSP5,2
KEGG_NON_SMALL_CELL_LUNG_CANCER,KEGG_NON_SMALL_CELL_LUNG_CANCER,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,ERBB2,1
KEGG_VIBRIO_CHOLERAE_INFECTION,KEGG_VIBRIO_CHOLERAE_INFECTION,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,PRKACA,1
MORI_PLASMA_CELL_UP,MORI_PLASMA_CELL_UP,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,RRBP1,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,PML,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,PML,1
REACTOME_G_PROTEIN_MEDIATED_EVENTS,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,PRKACA,1
REACTOME_ION_HOMEOSTASIS,REACTOME_ION_HOMEOSTASIS,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,PRKACA,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,ERBB2,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,TRIP10,1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1/50,54/21728,0.11711380721805964,0.21476183176499766,0.16022740869931007,NAB2,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,2/50,256/21728,0.11736181063291176,0.2149238055944207,0.16034825255108892,PML/ERBB2,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/50,258/21728,0.11886976750390076,0.2167251851117757,0.16169220817755064,SDC4/LRPAP1,2
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/50,55/21728,0.11915054753544874,0.2167251851117757,0.16169220817755064,DHCR7,1
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1/50,55/21728,0.11915054753544874,0.2167251851117757,0.16169220817755064,RRBP1,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/50,55/21728,0.11915054753544874,0.2167251851117757,0.16169220817755064,MAP2K3,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/50,55/21728,0.11915054753544874,0.2167251851117757,0.16169220817755064,MAP2K7,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1/50,56/21728,0.12118268303229895,0.2189421360556703,0.16334620927278448,PML,1
KEGG_HEDGEHOG_SIGNALING_PATHWAY,KEGG_HEDGEHOG_SIGNALING_PATHWAY,1/50,56/21728,0.12118268303229895,0.2189421360556703,0.16334620927278448,PRKACA,1
LEE_LIVER_CANCER_MYC_E2F1_UP,LEE_LIVER_CANCER_MYC_E2F1_UP,1/50,56/21728,0.12118268303229895,0.2189421360556703,0.16334620927278448,LAMA5,1
MCCLUNG_CREB1_TARGETS_DN,MCCLUNG_CREB1_TARGETS_DN,1/50,56/21728,0.12118268303229895,0.2189421360556703,0.16334620927278448,DHCR7,1
PID_TXA2PATHWAY,PID_TXA2PATHWAY,1/50,56/21728,0.12118268303229895,0.2189421360556703,0.16334620927278448,PRKACA,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,2/50,262/21728,0.12190051728572535,0.21994382877558488,0.16409354238829124,LAMA5/SLC12A4,2
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/50,57/21728,0.12321022390754743,0.2211212818394118,0.1649720050635793,PHLDA3,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/50,57/21728,0.12321022390754743,0.2211212818394118,0.1649720050635793,PML,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/50,57/21728,0.12321022390754743,0.2211212818394118,0.1649720050635793,PRKACA,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/50,57/21728,0.12321022390754743,0.2211212818394118,0.1649720050635793,FOSL1,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,2/50,266/21728,0.12495055049097602,0.2229680697552452,0.16634983854422766,NPAS2/ACTN4,2
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,1/50,58/21728,0.1252331803380129,0.2229680697552452,0.16634983854422766,DUSP5,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/50,58/21728,0.1252331803380129,0.2229680697552452,0.16634983854422766,HOMER2,1
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,1/50,58/21728,0.1252331803380129,0.2229680697552452,0.16634983854422766,SDC4,1
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,1/50,58/21728,0.1252331803380129,0.2229680697552452,0.16634983854422766,FURIN,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/50,58/21728,0.1252331803380129,0.2229680697552452,0.16634983854422766,SLC12A4,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,2/50,267/21728,0.12571600251909837,0.22353202033118416,0.16677058527875943,EPHA2/MAP2K3,2
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,SDC4,1
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,ERBB2,1
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,DUSP5,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,FURIN,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,TRIP10,1
ZHENG_IL22_SIGNALING_UP,ZHENG_IL22_SIGNALING_UP,1/50,59/21728,0.12725156247844227,0.22448309711138045,0.16748015534860172,SBNO2,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,2/50,270/21728,0.12801927734724844,0.22554181584999528,0.16827003387885786,EPHB4/RRBP1,2
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,DUSP5,1
LEE_LIVER_CANCER_DENA_UP,LEE_LIVER_CANCER_DENA_UP,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,LAMA5,1
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,MAP2K7,1
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,PRKACA,1
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,CRIM1,1
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1/50,60/21728,0.12926538046155556,0.2259626001314984,0.1685839685035188,LMNA,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,2/50,272/21728,0.12956046899937618,0.2261846838821794,0.16874965857793006,NPAS2/FOSL1,2
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1/50,61/21728,0.13127464439809433,0.2288804033158484,0.17076085458928553,CD151,1
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,2/50,275/21728,0.1318805896158992,0.22963942253945713,0.17132713623417697,LAMA5/CRIM1,2
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/50,62/21728,0.13327936437686816,0.2308803403491178,0.17225294806683228,DUSP5,1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/50,62/21728,0.13327936437686816,0.2308803403491178,0.17225294806683228,ACTN4,1
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,1/50,62/21728,0.13327936437686816,0.2308803403491178,0.17225294806683228,MAP2K3,1
WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1/50,62/21728,0.13327936437686816,0.2308803403491178,0.17225294806683228,MAP2K7,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/50,279/21728,0.1349892662325533,0.23254952097780623,0.17349827403834142,TRIP10/LAMA5,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/50,279/21728,0.1349892662325533,0.23254952097780623,0.17349827403834142,SDC4/MAP2K7,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,1/50,63/21728,0.1352795504648011,0.23254952097780623,0.17349827403834142,TRIP10,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/50,63/21728,0.1352795504648011,0.23254952097780623,0.17349827403834142,ERBB2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1/50,63/21728,0.1352795504648011,0.23254952097780623,0.17349827403834142,PRKACA,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/50,63/21728,0.1352795504648011,0.23254952097780623,0.17349827403834142,ERBB2,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/50,64/21728,0.13727521270697807,0.23478073227902477,0.1751629143616092,RRBP1,1
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,1/50,64/21728,0.13727521270697807,0.23478073227902477,0.1751629143616092,SIPA1L1,1
REACTOME_COLLAGEN_DEGRADATION,REACTOME_COLLAGEN_DEGRADATION,1/50,64/21728,0.13727521270697807,0.23478073227902477,0.1751629143616092,FURIN,1
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,1/50,64/21728,0.13727521270697807,0.23478073227902477,0.1751629143616092,ERBB2,1
BRIDEAU_IMPRINTED_GENES,BRIDEAU_IMPRINTED_GENES,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,DHCR7,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,DUSP5,1
PID_CD8_TCR_DOWNSTREAM_PATHWAY,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,FOSL1,1
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,PVR,1
REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,LMNA,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,DUSP5,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,PRKACA,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/50,65/21728,0.13926636112669033,0.2357893359453147,0.17591540352845098,PRKACA,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,2/50,286/21728,0.14046963155288322,0.23588901452419547,0.17598977074848088,LDLR/SDC4,2
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,PARVB,1
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,DHCR7,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,DUSP5,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,SDC4,1
PID_HDAC_CLASSI_PATHWAY,PID_HDAC_CLASSI_PATHWAY,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,PRKACA,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,FURIN,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,LAMA5,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,FOSL1,1
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,LDLR,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/50,66/21728,0.14125300572548405,0.23588901452419547,0.17598977074848088,ERBB2,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,2/50,288/21728,0.14204450745869926,0.2369168612632084,0.17675661659896838,SDC4/LMNA,2
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,2/50,289/21728,0.14283341247444928,0.23793783810718902,0.1775183370253057,TRIP10/DUSP5,2
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,1/50,67/21728,0.14323515648320384,0.23801792669924982,0.17757808873941064,PML,1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,1/50,67/21728,0.14323515648320384,0.23801792669924982,0.17757808873941064,SIPA1L1,1
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,1/50,68/21728,0.14521282335804053,0.23982387759499701,0.1789254549351898,PML,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/50,68/21728,0.14521282335804053,0.23982387759499701,0.1789254549351898,FURIN,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/50,68/21728,0.14521282335804053,0.23982387759499701,0.1789254549351898,ERBB2,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/50,68/21728,0.14521282335804053,0.23982387759499701,0.1789254549351898,MAP2K3,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1/50,68/21728,0.14521282335804053,0.23982387759499701,0.1789254549351898,SDC4,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,2/50,293/21728,0.14599861736006137,0.24082615069441493,0.1796732210545647,EPHA2/EHD2,2
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,CD151,1
LEIN_NEURON_MARKERS,LEIN_NEURON_MARKERS,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,PRKACA,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,PML,1
RIZKI_TUMOR_INVASIVENESS_2D_UP,RIZKI_TUMOR_INVASIVENESS_2D_UP,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,NAB2,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,PML,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/50,69/21728,0.1471860162865768,0.24101262520892017,0.1798123441380385,ERBB2,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,2/50,295/21728,0.14758685434416705,0.24137534136968267,0.18008295586664372,SIPA1L1/BCAM,2
CROONQUIST_NRAS_SIGNALING_DN,CROONQUIST_NRAS_SIGNALING_DN,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,SBNO2,1
DITTMER_PTHLH_TARGETS_DN,DITTMER_PTHLH_TARGETS_DN,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,LMNA,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,FURIN,1
KEGG_LONG_TERM_POTENTIATION,KEGG_LONG_TERM_POTENTIATION,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,PRKACA,1
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,ERBB2,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,FOSL1,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,NPAS2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,1/50,70/21728,0.14915474518383331,0.24159119978031246,0.1802440014001862,RRBP1,1
BURTON_ADIPOGENESIS_2,BURTON_ADIPOGENESIS_2,1/50,71/21728,0.15111901994331256,0.24389232715071787,0.18196080402110337,FOSL1,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/50,71/21728,0.15111901994331256,0.24389232715071787,0.18196080402110337,NPAS2,1
REACTOME_SARS_COV_2_INFECTION,REACTOME_SARS_COV_2_INFECTION,1/50,71/21728,0.15111901994331256,0.24389232715071787,0.18196080402110337,FURIN,1
CHANG_IMMORTALIZED_BY_HPV31_UP,CHANG_IMMORTALIZED_BY_HPV31_UP,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,SSH3,1
MATZUK_SPERMATOCYTE,MATZUK_SPERMATOCYTE,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,LMNA,1
REACTOME_AURKA_ACTIVATION_BY_TPX2,REACTOME_AURKA_ACTIVATION_BY_TPX2,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,PRKACA,1
REACTOME_GLYCOLYSIS,REACTOME_GLYCOLYSIS,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,PRKACA,1
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,ERBB2,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,PML,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1/50,72/21728,0.15307885043704827,0.24499896871375385,0.18278643634388145,PNPLA2,1
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,1/50,73/21728,0.15503424651564723,0.24666205178494227,0.18402721310927894,PHLDA3,1
FURUKAWA_DUSP6_TARGETS_PCI35_DN,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1/50,73/21728,0.15503424651564723,0.24666205178494227,0.18402721310927894,EPHA2,1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/50,73/21728,0.15503424651564723,0.24666205178494227,0.18402721310927894,DUSP5,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/50,73/21728,0.15503424651564723,0.24666205178494227,0.18402721310927894,NAB2,1
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,1/50,73/21728,0.15503424651564723,0.24666205178494227,0.18402721310927894,LDLR,1
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/50,74/21728,0.15698521800833853,0.24888351406268983,0.18568457997638704,PML,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1/50,74/21728,0.15698521800833853,0.24888351406268983,0.18568457997638704,SH2D4A,1
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,1/50,74/21728,0.15698521800833853,0.24888351406268983,0.18568457997638704,EPHA2,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,2/50,308/21728,0.15799692131122484,0.2501927718645984,0.18666137824261114,FURIN/PRKACA,2
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,2/50,309/21728,0.15880360926742582,0.2506207233757998,0.18698066012396422,DUSP5/SDC4,2
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,2/50,309/21728,0.15880360926742582,0.2506207233757998,0.18698066012396422,EPHA2/LAMA5,2
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1/50,75/21728,0.15893177472301423,0.2506207233757998,0.18698066012396422,FURIN,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,ACTN4,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,LDLR,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,LAMA5,1
REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,LMNA,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,DUSP5,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,MAP2K3,1
WP_16P112_PROXIMAL_DELETION_SYNDROME,WP_16P112_PROXIMAL_DELETION_SYNDROME,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,MAP2K3,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,ERBB2,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,ERBB2,1
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,ERBB2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1/50,76/21728,0.16087392644627863,0.2506207233757998,0.18698066012396422,SDC4,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,ERBB2,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,MAP2K3,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,SDC4,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,ACTN4,1
REACTOME_MEIOTIC_SYNAPSIS,REACTOME_MEIOTIC_SYNAPSIS,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,LMNA,1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,PML,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1/50,77/21728,0.1628116829434929,0.2516010622754781,0.18771206178994773,SDC4,1
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,PML,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,PML,1
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,ALG12,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,ERBB2,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,PRKACA,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,FOSL1,1
WONG_ENDMETRIUM_CANCER_DN,WONG_ENDMETRIUM_CANCER_DN,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,EHD2,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/50,78/21728,0.16474505395881878,0.25227172085161553,0.18821242018647166,LDLR,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,2/50,317/21728,0.16528546253541923,0.2528116279234935,0.18861522877845688,PVR/ERBB2,2
BILD_CTNNB1_ONCOGENIC_SIGNATURE,BILD_CTNNB1_ONCOGENIC_SIGNATURE,1/50,79/21728,0.1666740492152653,0.2534952206144035,0.18912523693293265,DUSP5,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/50,79/21728,0.1666740492152653,0.2534952206144035,0.18912523693293265,FOSL1,1
PID_P73PATHWAY,PID_P73PATHWAY,1/50,79/21728,0.1666740492152653,0.2534952206144035,0.18912523693293265,PML,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,1/50,79/21728,0.1666740492152653,0.2534952206144035,0.18912523693293265,BCAM,1
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,1/50,79/21728,0.1666740492152653,0.2534952206144035,0.18912523693293265,LAMA5,1
BOYLAN_MULTIPLE_MYELOMA_D_DN,BOYLAN_MULTIPLE_MYELOMA_D_DN,1/50,80/21728,0.16859867841473086,0.25584421775222965,0.19087775376212338,NAB2,1
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,1/50,80/21728,0.16859867841473086,0.25584421775222965,0.19087775376212338,EPHA2,1
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,2/50,323/21728,0.17017833008179595,0.2564452607446017,0.1913261740442246,PML/ERBB2,2
LEI_MYB_TARGETS,LEI_MYB_TARGETS,2/50,323/21728,0.17017833008179595,0.2564452607446017,0.1913261740442246,LAMA5/CRIM1,2
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,NPAS2,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,ACTN4,1
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,PRKACA,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,TRPM4,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,LDLR,1
WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,1/50,81/21728,0.17051895123805239,0.2564452607446017,0.1913261740442246,PML,1
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,1/50,82/21728,0.1724348773450466,0.2584602949960275,0.19282953110675707,LAMA5,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/50,82/21728,0.1724348773450466,0.2584602949960275,0.19282953110675707,PRKACA,1
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,1/50,82/21728,0.1724348773450466,0.2584602949960275,0.19282953110675707,LMNA,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,2/50,327/21728,0.1734543353279559,0.2595596474981245,0.19364972527818158,RRP1/ERBB2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/50,83/21728,0.1743464663745551,0.2595596474981245,0.19364972527818158,NAB2,1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/50,83/21728,0.1743464663745551,0.2595596474981245,0.19364972527818158,LMNA,1
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,1/50,83/21728,0.1743464663745551,0.2595596474981245,0.19364972527818158,HOMER2,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/50,83/21728,0.1743464663745551,0.2595596474981245,0.19364972527818158,PHLDA3,1
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,1/50,83/21728,0.1743464663745551,0.2595596474981245,0.19364972527818158,NAB2,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,DHCR7,1
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,LMNA,1
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,DUSP5,1
HILLION_HMGA1_TARGETS,HILLION_HMGA1_TARGETS,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,ERBB2,1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,MAP2K3,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,LAMA5,1
LEIN_MIDBRAIN_MARKERS,LEIN_MIDBRAIN_MARKERS,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,PHLDA3,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,TOM1,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,ERBB2,1
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,1/50,84/21728,0.17625372794449168,0.2595596474981245,0.19364972527818158,CD151,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/50,85/21728,0.17815667165188287,0.2609345811136391,0.19467552231360893,DUSP5,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1/50,85/21728,0.17815667165188287,0.2609345811136391,0.19467552231360893,PVR,1
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1/50,85/21728,0.17815667165188287,0.2609345811136391,0.19467552231360893,PRKACA,1
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,1/50,85/21728,0.17815667165188287,0.2609345811136391,0.19467552231360893,MAP2K7,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/50,85/21728,0.17815667165188287,0.2609345811136391,0.19467552231360893,MAP2K3,1
COATES_MACROPHAGE_M1_VS_M2_UP,COATES_MACROPHAGE_M1_VS_M2_UP,1/50,86/21728,0.1800553070729154,0.26228835857158456,0.19568553536974403,CRIM1,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/50,86/21728,0.1800553070729154,0.26228835857158456,0.19568553536974403,PARVB,1
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,1/50,86/21728,0.1800553070729154,0.26228835857158456,0.19568553536974403,ERBB2,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/50,86/21728,0.1800553070729154,0.26228835857158456,0.19568553536974403,MAP2K3,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/50,86/21728,0.1800553070729154,0.26228835857158456,0.19568553536974403,DHCR7,1
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,PRKACA,1
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,XYLT2,1
REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,MAP2K7,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,FURIN,1
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,PRKACA,1
SMITH_TERT_TARGETS_DN,SMITH_TERT_TARGETS_DN,1/50,87/21728,0.18194964376297873,0.26333787151071975,0.1964685457270874,PML,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/50,88/21728,0.18383969125671085,0.26465050741340407,0.19744786429372607,OSBPL10,1
JIANG_VHL_TARGETS,JIANG_VHL_TARGETS,1/50,88/21728,0.18383969125671085,0.26465050741340407,0.19744786429372607,TRIP10,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/50,88/21728,0.18383969125671085,0.26465050741340407,0.19744786429372607,EPHA2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/50,88/21728,0.18383969125671085,0.26465050741340407,0.19744786429372607,PML,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/50,88/21728,0.18383969125671085,0.26465050741340407,0.19744786429372607,DHCR7,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/50,89/21728,0.18572545906804006,0.26622627039998076,0.1986234941437254,ERBB2,1
REACTOME_BASE_EXCISION_REPAIR,REACTOME_BASE_EXCISION_REPAIR,1/50,89/21728,0.18572545906804006,0.26622627039998076,0.1986234941437254,PNKP,1
WNT_SIGNALING,WNT_SIGNALING,1/50,89/21728,0.18572545906804006,0.26622627039998076,0.1986234941437254,FOSL1,1
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1/50,89/21728,0.18572545906804006,0.26622627039998076,0.1986234941437254,ERBB2,1
KEGG_GAP_JUNCTION,KEGG_GAP_JUNCTION,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,PRKACA,1
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,CD151,1
REACTOME_OPIOID_SIGNALLING,REACTOME_OPIOID_SIGNALLING,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,PRKACA,1
REACTOME_SPHINGOLIPID_METABOLISM,REACTOME_SPHINGOLIPID_METABOLISM,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,ARSJ,1
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,CRIM1,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/50,90/21728,0.18760695669023142,0.26721583460852005,0.19936177853799028,FOSL1,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,2/50,345/21728,0.1883225681704722,0.26766861326024877,0.19969958320972656,EPHA2/LAMA5,2
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/50,345/21728,0.1883225681704722,0.26766861326024877,0.19969958320972656,PVR/DHCR7,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1/50,91/21728,0.18948419359592916,0.2681868817877189,0.2000862479279611,ERBB2,1
LU_IL4_SIGNALING,LU_IL4_SIGNALING,1/50,91/21728,0.18948419359592916,0.2681868817877189,0.2000862479279611,HOMER2,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/50,91/21728,0.18948419359592916,0.2681868817877189,0.2000862479279611,ACTN4,1
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,1/50,91/21728,0.18948419359592916,0.2681868817877189,0.2000862479279611,LDLR,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/50,92/21728,0.19135717923720108,0.26998612500343044,0.20142860972336957,FOSL1,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1/50,92/21728,0.19135717923720108,0.26998612500343044,0.20142860972336957,SDC4,1
REACTOME_GLUCOSE_METABOLISM,REACTOME_GLUCOSE_METABOLISM,1/50,92/21728,0.19135717923720108,0.26998612500343044,0.20142860972336957,PRKACA,1
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,1/50,93/21728,0.19322592304558273,0.27120134767398785,0.2023352511777465,PML,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/50,93/21728,0.19322592304558273,0.27120134767398785,0.2023352511777465,PRKACA,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/50,93/21728,0.19322592304558273,0.27120134767398785,0.2023352511777465,EHD2,1
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,1/50,93/21728,0.19322592304558273,0.27120134767398785,0.2023352511777465,FOSL1,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/50,93/21728,0.19322592304558273,0.27120134767398785,0.2023352511777465,PML,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/50,94/21728,0.19509043443211915,0.27268091873897443,0.2034391150989143,LMNA,1
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,1/50,94/21728,0.19509043443211915,0.27268091873897443,0.2034391150989143,RCE1,1
REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1/50,94/21728,0.19509043443211915,0.27268091873897443,0.2034391150989143,PRKACA,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/50,94/21728,0.19509043443211915,0.27268091873897443,0.2034391150989143,EPHA2,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,2/50,354/21728,0.19582540857940361,0.2734242738048519,0.20399371018208243,LDLR/SDC4,2
CROONQUIST_IL6_DEPRIVATION_DN,CROONQUIST_IL6_DEPRIVATION_DN,1/50,95/21728,0.19695072278741155,0.27357654579138896,0.20410731577773136,SBNO2,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/50,95/21728,0.19695072278741155,0.27357654579138896,0.20410731577773136,LAMA5,1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1/50,95/21728,0.19695072278741155,0.27357654579138896,0.20410731577773136,PRKACA,1
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1/50,95/21728,0.19695072278741155,0.27357654579138896,0.20410731577773136,PRKACA,1
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,1/50,95/21728,0.19695072278741155,0.27357654579138896,0.20410731577773136,SDC4,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/50,96/21728,0.19880679748165775,0.275019475241841,0.20518384248120464,LRPAP1,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/50,96/21728,0.19880679748165775,0.275019475241841,0.20518384248120464,DHCR7,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/50,96/21728,0.19880679748165775,0.275019475241841,0.20518384248120464,TEAD3,1
WP_G_PROTEIN_SIGNALING_PATHWAYS,WP_G_PROTEIN_SIGNALING_PATHWAYS,1/50,96/21728,0.19880679748165775,0.275019475241841,0.20518384248120464,PRKACA,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,2/50,359/21728,0.20001094806448896,0.2764011664217681,0.20621468113425107,TRIP10/DUSP5,2
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/50,97/21728,0.20065866786469777,0.27672803990356887,0.20645855170720634,SBNO2,1
REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1/50,97/21728,0.20065866786469777,0.27672803990356887,0.20645855170720634,PRKACA,1
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,1/50,98/21728,0.2025063432660552,0.2787050491166772,0.20793353942074774,PVR,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/50,98/21728,0.2025063432660552,0.2787050491166772,0.20793353942074774,LAMA5,1
ROVERSI_GLIOMA_COPY_NUMBER_UP,ROVERSI_GLIOMA_COPY_NUMBER_UP,1/50,99/21728,0.20434983299498233,0.2809549287142454,0.20961210760412147,BCAM,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,2/50,366/21728,0.20588956262352406,0.28261770974981293,0.21085265902973455,MAP2K3/LMNA,2
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,1/50,100/21728,0.20618914634050245,0.28261770974981293,0.21085265902973455,SIPA1L1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1/50,100/21728,0.20618914634050245,0.28261770974981293,0.21085265902973455,HOMER2,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,2/50,367/21728,0.20673105159650784,0.2830722232440484,0.21119175801581463,RRP1/FURIN,2
GAVIN_FOXP3_TARGETS_CLUSTER_T7,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,LRPAP1,1
KEGG_MELANOGENESIS,KEGG_MELANOGENESIS,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,PRKACA,1
MCCLUNG_CREB1_TARGETS_UP,MCCLUNG_CREB1_TARGETS_UP,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,LMNA,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,MAP2K3,1
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,LMNA,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/50,101/21728,0.20802429257145172,0.2831149623874358,0.21122364441824804,DUSP5,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,2/50,369/21728,0.2084152326507612,0.28336050823022685,0.21140683886105924,CD151/BCAM,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/50,102/21728,0.2098552809365245,0.284170229517668,0.21201094780625265,SIPA1L1,1
GRADE_COLON_AND_RECTAL_CANCER_DN,GRADE_COLON_AND_RECTAL_CANCER_DN,1/50,102/21728,0.2098552809365245,0.284170229517668,0.21201094780625265,PARVB,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/50,102/21728,0.2098552809365245,0.284170229517668,0.21201094780625265,CRIM1,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/50,102/21728,0.2098552809365245,0.284170229517668,0.21201094780625265,BCAM,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/50,103/21728,0.2116821206643138,0.28606840804635175,0.21342712229312552,TRIP10,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/50,103/21728,0.2116821206643138,0.28606840804635175,0.21342712229312552,FOSL1,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,2/50,375/21728,0.21347696107506253,0.28766515417084815,0.21461840703760787,DHCR7/LDLR,2
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1/50,104/21728,0.2135048209633561,0.28766515417084815,0.21461840703760787,FURIN,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/50,104/21728,0.2135048209633561,0.28766515417084815,0.21461840703760787,MAP2K3,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/50,105/21728,0.2153233910221718,0.2892467907343745,0.2157984189884987,LDLR,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/50,105/21728,0.2153233910221718,0.2892467907343745,0.2157984189884987,ERBB2,1
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,1/50,105/21728,0.2153233910221718,0.2892467907343745,0.2157984189884987,LAMA5,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,2/50,378/21728,0.2160126934564607,0.2898834350871347,0.2162734003856468,SDC4/PML,2
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/50,106/21728,0.21713784000931002,0.29052438633452415,0.21675159502865105,PRKACA,1
REACTOME_STIMULI_SENSING_CHANNELS,REACTOME_STIMULI_SENSING_CHANNELS,1/50,106/21728,0.21713784000931002,0.29052438633452415,0.21675159502865105,TRPM4,1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1/50,106/21728,0.21713784000931002,0.29052438633452415,0.21675159502865105,SLC12A4,1
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1/50,107/21728,0.2189481770733901,0.2920755662445818,0.21790888417715737,RCE1,1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1/50,107/21728,0.2189481770733901,0.2920755662445818,0.21790888417715737,TOM1,1
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,1/50,107/21728,0.2189481770733901,0.2920755662445818,0.21790888417715737,PML,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,PHLDA3,1
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,LAMA5,1
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,MAP2K7,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,ARSJ,1
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,FURIN,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/50,108/21728,0.22075441134314266,0.29274427356440397,0.21840778679943804,PRKACA,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,2/50,385/21728,0.2219409183296107,0.2940280276295827,0.21936555748699607,EPHA2/ARSJ,2
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/50,110/21728,0.22435460791541173,0.2966417507408096,0.2213155784834069,DUSP5,1
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,1/50,110/21728,0.22435460791541173,0.2966417507408096,0.2213155784834069,LAMA5,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/50,111/21728,0.22614858837633456,0.2981823283486211,0.22246495756986356,LAMA5,1
ZWANG_EGF_INTERVAL_UP,ZWANG_EGF_INTERVAL_UP,1/50,111/21728,0.22614858837633456,0.2981823283486211,0.22246495756986356,SH2D4A,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,2/50,390/21728,0.22618436645166576,0.2981823283486211,0.22246495756986356,PML/SSH3,2
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/50,112/21728,0.22793850235982838,0.2999073550110743,0.22375194860449277,PML,1
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,1/50,112/21728,0.22793850235982838,0.2999073550110743,0.22375194860449277,EPHA2,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/50,113/21728,0.22972435889582077,0.3010798316200338,0.22462669849496547,PML,1
KEGG_OOCYTE_MEIOSIS,KEGG_OOCYTE_MEIOSIS,1/50,113/21728,0.22972435889582077,0.3010798316200338,0.22462669849496547,PRKACA,1
REACTOME_HEDGEHOG_OFF_STATE,REACTOME_HEDGEHOG_OFF_STATE,1/50,113/21728,0.22972435889582077,0.3010798316200338,0.22462669849496547,PRKACA,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/50,113/21728,0.22972435889582077,0.3010798316200338,0.22462669849496547,ERBB2,1
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,1/50,114/21728,0.23150616699460425,0.3022379250967384,0.2254907175586834,HOMER2,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/50,114/21728,0.23150616699460425,0.3022379250967384,0.2254907175586834,PRKACA,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/50,114/21728,0.23150616699460425,0.3022379250967384,0.2254907175586834,LDLR,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/50,114/21728,0.23150616699460425,0.3022379250967384,0.2254907175586834,PRKACA,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1/50,115/21728,0.23328393564687921,0.3036752199039646,0.22656304042260286,BCAM,1
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1/50,115/21728,0.23328393564687921,0.3036752199039646,0.22656304042260286,PRKACA,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/50,115/21728,0.23328393564687921,0.3036752199039646,0.22656304042260286,ERBB2,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,2/50,399/21728,0.23383898457488694,0.3041036456403844,0.22688267610927246,LDLR/EPS8L1,2
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/50,116/21728,0.23505767382379383,0.3048050375402953,0.2274059637236582,BCAM,1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/50,116/21728,0.23505767382379383,0.3048050375402953,0.2274059637236582,ACTN4,1
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1/50,116/21728,0.23505767382379383,0.3048050375402953,0.2274059637236582,DUSP5,1
REACTOME_MEIOSIS,REACTOME_MEIOSIS,1/50,117/21728,0.23682739047698687,0.30621485838811174,0.22845778908442843,LMNA,1
WHITEFORD_PEDIATRIC_CANCER_MARKERS,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1/50,117/21728,0.23682739047698687,0.30621485838811174,0.22845778908442843,RRP1,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/50,117/21728,0.23682739047698687,0.30621485838811174,0.22845778908442843,FOSL1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/50,118/21728,0.23859309453862942,0.30761140349520616,0.2294997098102969,ERBB2,1
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,1/50,118/21728,0.23859309453862942,0.30761140349520616,0.2294997098102969,FURIN,1
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,1/50,118/21728,0.23859309453862942,0.30761140349520616,0.2294997098102969,MAP2K3,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1/50,119/21728,0.2403547949214646,0.3095861760423841,0.23097302881397863,BCAM,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/50,407/21728,0.24065806950812224,0.3096804603804326,0.23104337155152327,SDC4/PML,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/50,408/21728,0.2415113019512552,0.31048157824870054,0.23164106174181623,MAP2K3/FOSL1,2
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/50,120/21728,0.24211250051885125,0.3109574672694406,0.23199610837182014,NPAS2,1
CERVERA_SDHB_TARGETS_1_UP,CERVERA_SDHB_TARGETS_1_UP,1/50,121/21728,0.24386622020480342,0.31261326894825275,0.23323145270715037,EPS8L1,1
WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,1/50,121/21728,0.24386622020480342,0.31261326894825275,0.23323145270715037,PNKP,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,1/50,122/21728,0.24561596283403286,0.3136613718924177,0.23401341110922538,BCAM,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/50,122/21728,0.24561596283403286,0.3136613718924177,0.23401341110922538,EPS8L1,1
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,1/50,122/21728,0.24561596283403286,0.3136613718924177,0.23401341110922538,EPHA2,1
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1/50,122/21728,0.24561596283403286,0.3136613718924177,0.23401341110922538,FOSL1,1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1/50,123/21728,0.24736173724198895,0.3154539897775025,0.23535082994270543,LDLR,1
REACTOME_M_PHASE,REACTOME_M_PHASE,2/50,415/21728,0.24748841991459333,0.3154539897775025,0.23535082994270543,LMNA/PRKACA,2
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1/50,124/21728,0.24910355224490033,0.317212281288208,0.23666263889024042,PNPLA2,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1/50,125/21728,0.25084141663981574,0.3185212705633887,0.2376392368166676,SSH3,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/50,125/21728,0.25084141663981574,0.3185212705633887,0.2376392368166676,CRIM1,1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1/50,125/21728,0.25084141663981574,0.3185212705633887,0.2376392368166676,TOM1,1
EPPERT_HSC_R,EPPERT_HSC_R,1/50,126/21728,0.25257533920464514,0.3198178801217802,0.23860659860497252,CRIM1,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/50,126/21728,0.25257533920464514,0.3198178801217802,0.23860659860497252,MAP2K7,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/50,126/21728,0.25257533920464514,0.3198178801217802,0.23860659860497252,DUSP5,1
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,1/50,127/21728,0.2543053286981999,0.32110222554200474,0.2395648104849242,PRKACA,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/50,127/21728,0.2543053286981999,0.32110222554200474,0.2395648104849242,ACTN4,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1/50,127/21728,0.2543053286981999,0.32110222554200474,0.2395648104849242,ACTN4,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/50,128/21728,0.25603139386023366,0.3226848569106827,0.2407455646303209,XYLT2,1
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,2/50,425/21728,0.2560382074150142,0.3226848569106827,0.2407455646303209,LAMA5/ALG12,2
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1/50,129/21728,0.25775354341148327,0.3245428151841501,0.24213173198223137,FURIN,1
DANG_MYC_TARGETS_UP,DANG_MYC_TARGETS_UP,1/50,130/21728,0.25947178605370824,0.32579200002639114,0.2430637116017652,FOSL1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/50,130/21728,0.25947178605370824,0.32579200002639114,0.2430637116017652,ERBB2,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1/50,130/21728,0.25947178605370824,0.32579200002639114,0.2430637116017652,RCE1,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,2/50,431/21728,0.26117250031752953,0.32611923155126277,0.24330784929999588,CUL7/SBNO2,2
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/50,131/21728,0.2611861304697335,0.32611923155126277,0.24330784929999588,LAMA5,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/50,131/21728,0.2611861304697335,0.32611923155126277,0.24330784929999588,DUSP5,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/50,131/21728,0.2611861304697335,0.32611923155126277,0.24330784929999588,LMNA,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/50,131/21728,0.2611861304697335,0.32611923155126277,0.24330784929999588,ACTN4,1
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,1/50,131/21728,0.2611861304697335,0.32611923155126277,0.24330784929999588,LAMA5,1
KEGG_TIGHT_JUNCTION,KEGG_TIGHT_JUNCTION,1/50,132/21728,0.26289658532348714,0.32764704059760524,0.2444477021428916,ACTN4,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/50,132/21728,0.26289658532348714,0.32764704059760524,0.2444477021428916,ACTN4,1
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/50,133/21728,0.26460315926004174,0.32886043616252647,0.24535298044815074,ERBB2,1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/50,133/21728,0.26460315926004174,0.32886043616252647,0.24535298044815074,PRKACA,1
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,1/50,133/21728,0.26460315926004174,0.32886043616252647,0.24535298044815074,BCAM,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,2/50,436/21728,0.2654526875121639,0.3296119164127053,0.2459136374894197,FOSL1/LAMA5,2
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/50,134/21728,0.2663058609056538,0.3303665334368756,0.24647663478437423,SIPA1L1,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/50,135/21728,0.2680046988678062,0.3318623042098134,0.2475925848253398,TRPM4,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/50,135/21728,0.2680046988678062,0.3318623042098134,0.2475925848253398,PML,1
REACTOME_HCMV_EARLY_EVENTS,REACTOME_HCMV_EARLY_EVENTS,1/50,136/21728,0.26969968173524506,0.3333898832850819,0.24873226609366403,PML,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,2/50,441/21728,0.26973371686289316,0.3333898832850819,0.24873226609366403,TOM1/LRPAP1,2
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,1/50,137/21728,0.2713908180780219,0.3351303129660711,0.2500307488618377,LAMA5,1
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/50,138/21728,0.27307811644753244,0.3369048072762407,0.2513546462356563,SDC4,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/50,139/21728,0.27476158537655615,0.3374353046686538,0.25175043454594176,FOSL1,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/50,139/21728,0.27476158537655615,0.3374353046686538,0.25175043454594176,ACTN4,1
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,1/50,139/21728,0.27476158537655615,0.3374353046686538,0.25175043454594176,DUSP5,1
ODONNELL_TFRC_TARGETS_DN,ODONNELL_TFRC_TARGETS_DN,1/50,139/21728,0.27476158537655615,0.3374353046686538,0.25175043454594176,CD151,1
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,1/50,139/21728,0.27476158537655615,0.3374353046686538,0.25175043454594176,PML,1
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,1/50,140/21728,0.27644123337929705,0.33887969046314553,0.2528280477843442,PVR,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/50,140/21728,0.27644123337929705,0.33887969046314553,0.2528280477843442,PRKACA,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,2/50,450/21728,0.27743988298451217,0.339696528864441,0.2534374665962906,EPHA2/TRIP10,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1/50,141/21728,0.27811706895142196,0.339696528864441,0.2534374665962906,CD151,1
REACTOME_MITOTIC_PROPHASE,REACTOME_MITOTIC_PROPHASE,1/50,141/21728,0.27811706895142196,0.339696528864441,0.2534374665962906,LMNA,1
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,1/50,141/21728,0.27811706895142196,0.339696528864441,0.2534374665962906,PRKACA,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/50,142/21728,0.2797891005701012,0.34138686172262384,0.25469857361647236,SDC4,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,2/50,453/21728,0.28000824319597084,0.34138686172262384,0.25469857361647236,SIPA1L1/PHLDA3,2
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/50,143/21728,0.2814573366940468,0.3422236451582539,0.2553228728247237,SDC4,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/50,143/21728,0.2814573366940468,0.3422236451582539,0.2553228728247237,EPHA2,1
REACTOME_REPRODUCTION,REACTOME_REPRODUCTION,1/50,143/21728,0.2814573366940468,0.3422236451582539,0.2553228728247237,LMNA,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/50,144/21728,0.2831217857635532,0.34378222963759747,0.2564856863019223,RRBP1,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,2/50,458/21728,0.28428795214104186,0.34378222963759747,0.2564856863019223,SIPA1L1/SBNO2,2
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,CRIM1,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,NPAS2,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,LMNA,1
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,EPHA2,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,PNPLA2,1
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,1/50,145/21728,0.28478245620053577,0.34378222963759747,0.2564856863019223,EPHA2,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,2/50,459/21728,0.2851437221322256,0.34390990142470934,0.2565809384211878,PVR/PNKP,2
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/50,146/21728,0.28643935640856855,0.34454635721709853,0.25705577913905686,TRIP10,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,1/50,146/21728,0.28643935640856855,0.34454635721709853,0.25705577913905686,PNKP,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/50,146/21728,0.28643935640856855,0.34454635721709853,0.25705577913905686,DUSP5,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/50,147/21728,0.2880924947729263,0.3456082869557565,0.257848053300846,PARVB,1
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,1/50,147/21728,0.2880924947729263,0.3456082869557565,0.257848053300846,FOSL1,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/50,147/21728,0.2880924947729263,0.3456082869557565,0.257848053300846,RRBP1,1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1/50,148/21728,0.2897418796606216,0.34727744436615915,0.25909336194988336,DUSP5,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,2/50,467/21728,0.2919871229757539,0.3496571775136697,0.2608688100008141,EPHB4/RRBP1,2
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,1/50,150/21728,0.29302942238299956,0.35028206263545064,0.2613350181858293,PRKACA,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1/50,150/21728,0.29302942238299956,0.35028206263545064,0.2613350181858293,SSH3,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/50,152/21728,0.29630205114804253,0.35262825892596394,0.2630854453862279,ACTN4,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/50,152/21728,0.29630205114804253,0.35262825892596394,0.2630854453862279,SIPA1L1,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/50,152/21728,0.29630205114804253,0.35262825892596394,0.2630854453862279,CD151,1
REACTOME_HIV_LIFE_CYCLE,REACTOME_HIV_LIFE_CYCLE,1/50,152/21728,0.29630205114804253,0.35262825892596394,0.2630854453862279,FURIN,1
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1/50,152/21728,0.29630205114804253,0.35262825892596394,0.2630854453862279,PRKACA,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,2/50,473/21728,0.29711560225520584,0.35328409950133133,0.26357474851354507,SDC4/EPS8L1,2
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/50,153/21728,0.2979327935211701,0.3539431068662798,0.2640664142882857,DHCR7,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/50,154/21728,0.2995598322383861,0.35556219946461,0.2652743710715867,LDLR,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/50,155/21728,0.30118317553995666,0.3565457821255775,0.2660081928112935,PHLDA3,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/50,155/21728,0.30118317553995666,0.3565457821255775,0.2660081928112935,PARVB,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,1/50,155/21728,0.30118317553995666,0.3565457821255775,0.2660081928112935,PRKACA,1
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/50,156/21728,0.3028028316481939,0.35783372379145656,0.266969087743059,FURIN,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/50,156/21728,0.3028028316481939,0.35783372379145656,0.266969087743059,ERBB2,1
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,2/50,480/21728,0.3030931565263285,0.3578626216530159,0.2669906475772091,PHLDA3/SLC12A4,2
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/50,481/21728,0.30394652219472496,0.35855566947773865,0.26750770992552025,DUSP5/CRIM1,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/50,482/21728,0.3047997338172379,0.359247321994748,0.2680237312762881,ACTN4/RRBP1,2
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/50,158/21728,0.30603111508438585,0.3603830979033975,0.26887109986692836,PRKACA,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/50,484/21728,0.30650567994104005,0.3606264381124475,0.26905264875207235,RRP1/DHCR7,2
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,2/50,485/21728,0.3073584069938956,0.3613139002740467,0.26956554380342584,CD151/ERBB2,2
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/50,159/21728,0.3076397587675468,0.36132907094338396,0.2695768621881507,DHCR7,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/50,160/21728,0.30924474796786294,0.3622658231198812,0.2702757450976513,CD151,1
REACTOME_HCMV_INFECTION,REACTOME_HCMV_INFECTION,1/50,160/21728,0.30924474796786294,0.3622658231198812,0.2702757450976513,PML,1
REACTOME_REGULATION_OF_TP53_ACTIVITY,REACTOME_REGULATION_OF_TP53_ACTIVITY,1/50,160/21728,0.30924474796786294,0.3622658231198812,0.2702757450976513,PML,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/50,162/21728,0.3124437954347261,0.3653773663380898,0.27259717485456925,LAMA5,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/50,162/21728,0.3124437954347261,0.3653773663380898,0.27259717485456925,PRKACA,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/50,163/21728,0.3140378699143822,0.3669227195353806,0.2737501168661556,ERBB2,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/50,164/21728,0.3156283223374883,0.3678231358149431,0.2744218906447609,LDLR,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1/50,164/21728,0.3156283223374883,0.3678231358149431,0.2744218906447609,ERBB2,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/50,164/21728,0.3156283223374883,0.3678231358149431,0.2744218906447609,MAP2K3,1
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1/50,165/21728,0.3172151607664959,0.3690333676678509,0.27532480859867825,KLHDC4,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/50,165/21728,0.3172151607664959,0.3690333676678509,0.27532480859867825,SDC4,1
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/50,166/21728,0.31879839324628434,0.36959744815632967,0.2757456522570881,NPAS2,1
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,1/50,166/21728,0.31879839324628434,0.36959744815632967,0.2757456522570881,EPHB4,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/50,166/21728,0.31879839324628434,0.36959744815632967,0.2757456522570881,SSH3,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,1/50,166/21728,0.31879839324628434,0.36959744815632967,0.2757456522570881,FOSL1,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/50,167/21728,0.3203780278041959,0.37110914408300144,0.2768734835811241,PVR,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1/50,168/21728,0.32195407245007446,0.3726140855699056,0.2779962756187456,CRIM1,1
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,1/50,170/21728,0.32509542395784174,0.3752816815156561,0.2799864895330695,SDC4,1
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,1/50,170/21728,0.32509542395784174,0.3752816815156561,0.2799864895330695,FOSL1,1
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1/50,170/21728,0.32509542395784174,0.3752816815156561,0.2799864895330695,CRIM1,1
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,1/50,173/21728,0.3297807261233253,0.38003840527568145,0.28353533951122245,LAMA5,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/50,173/21728,0.3297807261233253,0.38003840527568145,0.28353533951122245,SIPA1L1,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/50,174/21728,0.3313353985285138,0.38150337589339567,0.28462831047337106,LAMA5,1
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1/50,175/21728,0.3328865366037468,0.3829617762979856,0.28571637959511875,EPS8L1,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/50,177/21728,0.3359782412319572,0.38618848223587904,0.2881237288285201,CRIM1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/50,178/21728,0.3375188234758624,0.38762827337756894,0.28919791413326096,HOMER2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/50,179/21728,0.339055902771742,0.3887301917638541,0.29002002263448573,XYLT2,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/50,179/21728,0.339055902771742,0.3887301917638541,0.29002002263448573,LMNA,1
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,1/50,180/21728,0.34058948692234803,0.3901561271467918,0.2910838705701412,LAMA5,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,1/50,182/21728,0.343646200913689,0.39298877351726885,0.2931972236924021,CD151,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/50,182/21728,0.343646200913689,0.39298877351726885,0.2931972236924021,SDC4,1
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,1/50,183/21728,0.3451693462749771,0.3933936833921415,0.29349931489489567,ERBB2,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/50,183/21728,0.3451693462749771,0.3933936833921415,0.29349931489489567,CRIM1,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/50,183/21728,0.3451693462749771,0.3933936833921415,0.29349931489489567,TRPM4,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/50,183/21728,0.3451693462749771,0.3933936833921415,0.29349931489489567,FOSL1,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/50,184/21728,0.34668902753217135,0.3947913968344354,0.29454210728087227,EPHA2,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/50,185/21728,0.3482052524032907,0.39584820078955174,0.295330557248168,LMNA,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/50,185/21728,0.3482052524032907,0.39584820078955174,0.295330557248168,MAP2K3,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1/50,186/21728,0.34971802858951506,0.39622934889014083,0.2956149204983142,SDC4,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/50,186/21728,0.34971802858951506,0.39622934889014083,0.2956149204983142,MAP2K7,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/50,186/21728,0.34971802858951506,0.39622934889014083,0.2956149204983142,EPHB4,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/50,186/21728,0.34971802858951506,0.39622934889014083,0.2956149204983142,MAP2K3,1
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,1/50,187/21728,0.35122736377522323,0.3969370542749374,0.29614291841580537,LMNA,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/50,187/21728,0.35122736377522323,0.3969370542749374,0.29614291841580537,PML,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1/50,187/21728,0.35122736377522323,0.3969370542749374,0.29614291841580537,LMNA,1
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,1/50,188/21728,0.35273326562802665,0.3983045096772851,0.29716313617903345,EPHA2,1
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,1/50,189/21728,0.35423574179880657,0.3996658075953006,0.2981787600265245,PRKACA,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1/50,190/21728,0.3557347999217493,0.4006853897026565,0.29893943988139077,LDLR,1
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,1/50,190/21728,0.3557347999217493,0.4006853897026565,0.29893943988139077,DUSP5,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1/50,191/21728,0.3572304476143814,0.4020335973987938,0.2999452975040661,PVR,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1/50,193/21728,0.3602115420957399,0.40471179938302665,0.3019434242679342,TEAD3,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/50,193/21728,0.3602115420957399,0.40471179938302665,0.3019434242679342,XYLT2,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/50,194/21728,0.3616970040365438,0.40536566813754205,0.3024312562784196,LRPAP1,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/50,194/21728,0.3616970040365438,0.40536566813754205,0.3024312562784196,SDC4,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,1/50,194/21728,0.3616970040365438,0.40536566813754205,0.3024312562784196,LAMA5,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/50,195/21728,0.36317908585126346,0.40634999963075696,0.3031656366995716,LAMA5,1
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,1/50,195/21728,0.36317908585126346,0.40634999963075696,0.3031656366995716,PRKACA,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,1/50,199/21728,0.3690737622980673,0.41225998676613995,0.30757490214663136,EPHA2,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/50,199/21728,0.3690737622980673,0.41225998676613995,0.30757490214663136,EHD2,1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/50,200/21728,0.37053905617539995,0.41252735286359665,0.30777437603180674,EPS8L1,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/50,200/21728,0.37053905617539995,0.41252735286359665,0.30777437603180674,DHCR7,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/50,200/21728,0.37053905617539995,0.41252735286359665,0.30777437603180674,FURIN,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/50,200/21728,0.37053905617539995,0.41252735286359665,0.30777437603180674,PRKACA,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/50,201/21728,0.3720010148892252,0.413812699207353,0.3087333346710056,DUSP5,1
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,1/50,202/21728,0.37345964587615055,0.4150922240704365,0.309687950076794,PRKACA,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/50,203/21728,0.3749149565565457,0.41568000949350126,0.3101264792811451,PML,1
REACTOME_MITOTIC_PROMETAPHASE,REACTOME_MITOTIC_PROMETAPHASE,1/50,203/21728,0.3749149565565457,0.41568000949350126,0.3101264792811451,PRKACA,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1/50,203/21728,0.3749149565565457,0.41568000949350126,0.3101264792811451,EHD2,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1/50,204/21728,0.3763669543345791,0.4168359510829886,0.3109888928858772,DUSP5,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,1/50,205/21728,0.3778156465982512,0.4168359510829886,0.3109888928858772,DUSP5,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,1/50,205/21728,0.3778156465982512,0.4168359510829886,0.3109888928858772,NPAS2,1
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1/50,205/21728,0.3778156465982512,0.4168359510829886,0.3109888928858772,PRKACA,1
REACTOME_RRNA_PROCESSING,REACTOME_RRNA_PROCESSING,1/50,205/21728,0.3778156465982512,0.4168359510829886,0.3109888928858772,RRP1,1
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1/50,205/21728,0.3778156465982512,0.4168359510829886,0.3109888928858772,DUSP5,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/50,206/21728,0.3792610407194279,0.4180879285899672,0.3119229560294274,RCE1,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/50,208/21728,0.3821419639413044,0.4209190535720096,0.31403517408907267,LMNA,1
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,1/50,212/21728,0.38786455525451935,0.4268730101165847,0.31847724380325476,OSBPL10,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/50,214/21728,0.3907063398863093,0.4296492920645199,0.32054854510796277,HOMER2,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/50,215/21728,0.3921223798140627,0.4305030368921112,0.3211854987057748,CRIM1,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/50,215/21728,0.3921223798140627,0.4305030368921112,0.3211854987057748,EPHB4,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/50,216/21728,0.3935351944382107,0.43170201443670064,0.3220800201553237,DHCR7,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/50,217/21728,0.39494479095541457,0.43254327797069814,0.3227076618315837,CRIM1,1
REACTOME_KERATINIZATION,REACTOME_KERATINIZATION,1/50,217/21728,0.39494479095541457,0.43254327797069814,0.3227076618315837,FURIN,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,1/50,218/21728,0.396351176546611,0.43337829702009617,0.3233306446837975,EPHB4,1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,1/50,218/21728,0.396351176546611,0.43337829702009617,0.3233306446837975,PRKACA,1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1/50,219/21728,0.397754358377047,0.4345595506294685,0.3242119428329656,RCE1,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/50,223/21728,0.4033351908488133,0.4395863699453463,0.32796230306394036,DUSP5,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/50,223/21728,0.4033351908488133,0.4395863699453463,0.32796230306394036,ERBB2,1
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1/50,223/21728,0.4033351908488133,0.4395863699453463,0.32796230306394036,PHLDA3,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/50,224/21728,0.4047224608073141,0.44074145003773857,0.3288240739313385,TOM1,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1/50,225/21728,0.406106569668904,0.4418912229380314,0.3296818852607195,DUSP5,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/50,227/21728,0.4088653323113205,0.44453371348225956,0.33165336878241625,ACTN4,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/50,228/21728,0.4102400001586034,0.44566831332807116,0.3324998599475873,NAB2,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/50,229/21728,0.4116115350419556,0.44643765202777774,0.33307384064635964,NPAS2,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/50,229/21728,0.4116115350419556,0.44643765202777774,0.33307384064635964,LRPAP1,1
COLDREN_GEFITINIB_RESISTANCE_DN,COLDREN_GEFITINIB_RESISTANCE_DN,1/50,230/21728,0.41297994395622617,0.44684164354106143,0.3333752466866135,EPS8L1,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,1/50,230/21728,0.41297994395622617,0.44684164354106143,0.3333752466866135,PNKP,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/50,230/21728,0.41297994395622617,0.44684164354106143,0.3333752466866135,LDLR,1
REACTOME_HIV_INFECTION,REACTOME_HIV_INFECTION,1/50,234/21728,0.4184224592849316,0.4520037160493724,0.337226515297647,FURIN,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/50,234/21728,0.4184224592849316,0.4520037160493724,0.337226515297647,CUL7,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/50,236/21728,0.42112514187997074,0.4538306172701686,0.3385895119072033,LDLR,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/50,236/21728,0.42112514187997074,0.4538306172701686,0.3385895119072033,PVR,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/50,236/21728,0.42112514187997074,0.4538306172701686,0.3385895119072033,LMNA,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1/50,237/21728,0.422471863586001,0.45455405946183636,0.3391292505877782,TOM1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1/50,237/21728,0.422471863586001,0.45455405946183636,0.3391292505877782,PML,1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1/50,238/21728,0.42381551473395607,0.45527189372059446,0.33966480535657084,DHCR7,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/50,238/21728,0.42381551473395607,0.45527189372059446,0.33966480535657084,LAMA5,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/50,239/21728,0.425156102182225,0.4563477779404106,0.34046749054129327,PHLDA3,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/50,240/21728,0.42649363277419716,0.45741866909487605,0.34126645054861326,HOMER2,1
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,1/50,243/21728,0.43048795162188846,0.4609680054757851,0.34391450475005786,LMNA,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/50,243/21728,0.43048795162188846,0.4609680054757851,0.34391450475005786,FOSL1,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/50,245/21728,0.4331356713622263,0.463434510058471,0.3457546903853769,FURIN,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/50,248/21728,0.43708464696518434,0.46691740858344294,0.3483531772805229,EPHA2,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1/50,248/21728,0.43708464696518434,0.46691740858344294,0.3483531772805229,SDC4,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,1/50,249/21728,0.4383949713437567,0.4675749852842287,0.348843775679326,FURIN,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/50,249/21728,0.4383949713437567,0.4675749852842287,0.348843775679326,SLC12A4,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/50,250/21728,0.43970230648192987,0.46859802416839086,0.34960703453245084,TRPM4,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/50,257/21728,0.4487705130408861,0.47788378999448783,0.35653486795553413,NAB2,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/50,259/21728,0.4513349043781474,0.4802346097177758,0.3582887445614751,SSH3,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/50,261/21728,0.45388760334248823,0.48256928443838004,0.36003057586158965,ACTN4,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/50,263/21728,0.45642866216229383,0.48488790786933506,0.3617604317723826,LDLR,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/50,265/21728,0.45895813283749076,0.4868066562641943,0.36319195282399425,EPHA2,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/50,265/21728,0.45895813283749076,0.4868066562641943,0.36319195282399425,EPHA2,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/50,266/21728,0.46021853880860963,0.48775917577668393,0.36390259927344687,MAP2K7,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/50,268/21728,0.46273072426940887,0.4900358417518681,0.3656011519756645,RRBP1,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1/50,269/21728,0.4639825166173368,0.49097521019413154,0.3663019868031607,SDC4,1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1/50,270/21728,0.4652314505923184,0.4919100805163084,0.3669994657171802,PRKACA,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/50,274/21728,0.47019873043236915,0.4967719710847479,0.37062677752002005,EPHA2,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/50,278/21728,0.4751207853094278,0.5015784917854822,0.3742127795130602,XYLT2,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/50,281/21728,0.4787828904039203,0.505048409469966,0.3768015817895892,SBNO2,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1/50,285/21728,0.483626770217927,0.5097585220934453,0.38031565658649175,CRIM1,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/50,289/21728,0.4884265260275802,0.5144147918882026,0.3837895608519163,CRIM1,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/50,290/21728,0.48961961682932553,0.515268181588954,0.3844262495001659,OSBPL10,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/50,296/21728,0.49672110786183543,0.521925535661226,0.3893931031679125,PHLDA3,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1/50,296/21728,0.49672110786183543,0.521925535661226,0.3893931031679125,PRKACA,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/50,297/21728,0.49789523741609554,0.5227511619048866,0.3900090783274121,RCE1,1
WEST_ADRENOCORTICAL_TUMOR_UP,WEST_ADRENOCORTICAL_TUMOR_UP,1/50,298/21728,0.4990666824316895,0.5235726847646562,0.3906219920743585,DHCR7,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/50,300/21728,0.5014015428855534,0.5252034838318715,0.39183868270556454,NPAS2,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,1/50,300/21728,0.5014015428855534,0.5252034838318715,0.39183868270556454,PML,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/50,305/21728,0.5071921338891647,0.5308558415356265,0.3960557385039397,ALG12,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/50,307/21728,0.5094898711323529,0.5328464386512409,0.39754086374699604,LDLR,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/50,308/21728,0.5106347993076659,0.5336292235000918,0.39812487621732046,CUL7,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/50,309/21728,0.5117771083662381,0.5344080588525651,0.3987059420859837,DHCR7,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1/50,311/21728,0.5140538925980525,0.5363694104162624,0.40016924809346566,PARVB,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/50,313/21728,0.5163202706289476,0.5383168739477641,0.40162219265360677,ERBB2,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/50,314/21728,0.5174495718882776,0.5390767211777258,0.40218909204938635,PRKACA,1
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,1/50,316/21728,0.5197004279213265,0.5410029203264545,0.4036261718866329,CD151,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,1/50,317/21728,0.5208219942674845,0.5417514716259925,0.4041846437250308,SDC4,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1/50,319/21728,0.5230574324549672,0.5436566054705682,0.405606007366014,MAP2K7,1
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,1/50,321/21728,0.5252826496029623,0.5455481839240643,0.40701725773328956,EPHA2,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/50,322/21728,0.5263914396024884,0.5462782403276402,0.40756193108044797,HOMER2,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1/50,323/21728,0.5274976914954096,0.5470045398712029,0.40810380154620124,CRIM1,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/50,325/21728,0.5297026037154191,0.5488681328721741,0.40949417280054284,DUSP5,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/50,327/21728,0.5318974316461331,0.5507184176889963,0.4108746152149077,DHCR7,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1/50,329/21728,0.5340822204715848,0.5525554717561515,0.4122451865608577,SLC49A3,1
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,1/50,330/21728,0.5351708642856147,0.5532565156132391,0.412768214510855,PNKP,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/50,333/21728,0.5384218605524171,0.5561901951677309,0.4149569454837065,LRPAP1,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/50,334/21728,0.5395005661832832,0.5568771181615791,0.41546943827805316,XYLT2,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/50,336/21728,0.5416505711099617,0.5582401751255808,0.4164863744973834,LMNA,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/50,336/21728,0.5416505711099617,0.5582401751255808,0.4164863744973834,MAP2K7,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1/50,339/21728,0.5448571456308817,0.5611153160054834,0.41863143150796217,PML,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,1/50,341/21728,0.5469826376466402,0.5628735705446313,0.4199432128721189,LMNA,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1/50,345/21728,0.551204480337675,0.566784744487785,0.42286122330597237,NPAS2,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/50,347/21728,0.553300918064696,0.5685061341336494,0.4241455008708075,CUL7,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1/50,350/21728,0.5564275918101211,0.5712826381208413,0.4262169678323945,NPAS2,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/50,359/21728,0.5656794859367176,0.580338862858858,0.43297354748365585,SDC4,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/50,364/21728,0.570737432739587,0.5850819379036436,0.4365122145617238,PARVB,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/50,366/21728,0.5727444083557209,0.5866925218012179,0.43771382325671543,PML,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/50,377/21728,0.5836194875249096,0.5969238831371795,0.44534713733703707,SLC49A3,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/50,377/21728,0.5836194875249096,0.5969238831371795,0.44534713733703707,CUL7,1
BENPORATH_ES_1,BENPORATH_ES_1,1/50,379/21728,0.5855674182952353,0.5984614616745533,0.4464942789063298,ERBB2,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/50,382/21728,0.588472580472582,0.6009742741396779,0.4483690134740383,PNKP,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/50,384/21728,0.59039825771574606,0.6020273143071169,0.4491546553914049,DUSP5,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/50,384/21728,0.59039825771574606,0.6020273143071169,0.4491546553914049,SLC12A4,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1/50,385/21728,0.59135778203706435,0.6020934755082364,0.44920401629378093,EPS8L1,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/50,385/21728,0.59135778203706435,0.6020934755082364,0.44920401629378093,CUL7,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,1/50,386/21728,0.59231510344915,0.6026123425869658,0.4495911275732897,RRBP1,1
KEGG_OLFACTORY_TRANSDUCTION,KEGG_OLFACTORY_TRANSDUCTION,1/50,389/21728,0.5951738997208094,0.6046068445465732,0.4510791661041924,PRKACA,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1/50,389/21728,0.5951738997208094,0.6046068445465732,0.4510791661041924,DUSP5,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,1/50,395/21728,0.6008326791504506,0.6098950121693111,0.4550245105259426,DUSP5,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1/50,398/21728,0.6036329260485651,0.6122757486521241,0.4568007071354708,CUL7,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/50,403/21728,0.6082572812635909,0.6165017323650552,0.45995358776590506,RCE1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1/50,409/21728,0.6137367516149077,0.6215874098372203,0.46374786031493564,LMNA,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/50,412/21728,0.6164482489523173,0.6233954493537334,0.46509678476848493,NPAS2,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/50,412/21728,0.6164482489523173,0.6233954493537334,0.46509678476848493,CRIM1,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/50,419/21728,0.622702741614912,0.6292476653255793,0.46946294887041734,RRP1,1
MOOTHA_PGC,MOOTHA_PGC,1/50,421/21728,0.6244713062632138,0.6305614240287215,0.47044310512504917,MAP2K3,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/50,425/21728,0.6279840970355429,0.6336331293926841,0.4727348130449838,RCE1,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/50,427/21728,0.6297283961367188,0.6349171694382199,0.4736927970939719,PML,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,1/50,434/21728,0.6357705549489792,0.6405293165878188,0.4778798529950569,EPS8L1,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1/50,438/21728,0.6391797225294398,0.6434823534215601,0.4800830258576433,SIPA1L1,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/50,445/21728,0.64507067404255,0.6489275988499794,0.484145561353625,RRP1,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/50,449/21728,0.6483945041054546,0.6517841691754607,0.48627676342644066,DHCR7,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/50,452/21728,0.650867339370897,0.6537816707412145,0.48776703987418374,PML,1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1/50,454/21728,0.6525064191049454,0.6549393289450086,0.4886307341937423,KLHDC4,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1/50,459/21728,0.6565711972752056,0.6585281904116443,0.49130827688489004,SLC49A3,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,1/50,466/21728,0.6621837037994363,0.6636628930111997,0.49513912562186957,CRIM1,1
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,1/50,479/21728,0.6723694436387522,0.6733699934060718,0.502381304222564,TOM1,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,1/50,483/21728,0.6754425194481197,0.6759447071949213,0.5043022215249512,FOSL1,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1/50,484/21728,0.676206363836333,0.676206363836333,0.5044974357549556,SLC12A4,1
